US20110117267A1 - Soft Prosthesis Shell Texturing Method - Google Patents
Soft Prosthesis Shell Texturing Method Download PDFInfo
- Publication number
- US20110117267A1 US20110117267A1 US13/010,929 US201113010929A US2011117267A1 US 20110117267 A1 US20110117267 A1 US 20110117267A1 US 201113010929 A US201113010929 A US 201113010929A US 2011117267 A1 US2011117267 A1 US 2011117267A1
- Authority
- US
- United States
- Prior art keywords
- shell
- flexible shell
- rounded
- salt particles
- microns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 150000003839 salts Chemical class 0.000 claims abstract description 64
- 239000013078 crystal Substances 0.000 claims abstract description 63
- 239000007943 implant Substances 0.000 claims abstract description 50
- 229920002379 silicone rubber Polymers 0.000 claims abstract description 20
- 210000000481 breast Anatomy 0.000 claims abstract description 14
- 239000002245 particle Substances 0.000 claims description 73
- 230000008569 process Effects 0.000 claims description 44
- 239000006185 dispersion Substances 0.000 claims description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 19
- 238000007598 dipping method Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 238000000465 moulding Methods 0.000 claims description 4
- 239000013536 elastomeric material Substances 0.000 claims description 2
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 abstract description 5
- 230000008602 contraction Effects 0.000 abstract description 2
- 230000000704 physical effect Effects 0.000 abstract description 2
- 239000002344 surface layer Substances 0.000 abstract 2
- 238000004873 anchoring Methods 0.000 abstract 1
- 230000036573 scar formation Effects 0.000 abstract 1
- 239000011257 shell material Substances 0.000 description 77
- 239000010410 layer Substances 0.000 description 32
- 239000002904 solvent Substances 0.000 description 20
- 239000007787 solid Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 239000000463 material Substances 0.000 description 13
- 230000004888 barrier function Effects 0.000 description 6
- 239000011148 porous material Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000001175 rotational moulding Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- -1 for example Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229960004716 idoxuridine Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/0086—Special surfaces of prostheses, e.g. for improving ingrowth for preferentially controlling or promoting the growth of specific types of cells or tissues
Definitions
- the present invention relates to soft prosthetic implants and, more particularly, to methods of texturing the exterior surface of such implants, for instance breast implants, to produce an open-cell texture on the outer surface.
- Implantable prostheses are commonly used to replace or augment body tissue. In the case of breast cancer, it is sometimes necessary to remove some or all of the mammary gland and surrounding tissue, which creates a void that can be filled with an implantable prosthesis.
- the implant serves to support surrounding tissue and to maintain the appearance of the body. The restoration of the normal appearance of the body has an extremely beneficial psychological effect on post-operative patients, eliminating much of the shock and depression that often follows extensive surgical procedures.
- Implantable prostheses are also used more generally for restoring the normal appearance of soft tissue in various areas of the body, such as the buttocks, chin, calf, etc.
- Soft implantable prostheses typically include a relatively thin and quite flexible envelope or shell made of vulcanized (cured) silicone elastomer.
- the shell is filled either with a silicone gel or with a normal saline solution. The filling of the shell takes place before or after the shell is inserted through an incision in the patient.
- the present invention provides processes for forming soft prosthetic implants having textured surfaces and implants formed by said processes.
- the processes generally comprise the steps of forming a flexible shell, adhering on the exterior of the flexible shell a distribution of rounded particles, curing the flexible shell with the rounded particles adhered thereto, and causing or allowing the rounded particles to be removed from the shell thereby leaving impressions of the particles in the shell to create an open-pored structure on a surface thereof.
- the flexible shell is formed of a silicone elastomer.
- the flexible shell may be formed of a plurality of layers of different silicone elastomers, or the flexible shell may be formed of a single homogeneous layer of a silicone elastomer.
- the step of forming the flexible shell may comprise dipping a mandrel into a liquid dispersion of elastomeric material.
- the step of forming comprises rotational molding.
- the step of adhering comprises dipping the flexible shell into a liquid containing the rounded particles, for example, a liquid dispersion or emulsion of rounded particles, for example, rounded salt crystals.
- a liquid containing the rounded particles for example, a liquid dispersion or emulsion of rounded particles, for example, rounded salt crystals.
- the process may also include applying a tack coat layer onto the flexible shell.
- the rounded particles comprise rounded crystals of sodium chloride and the solvent is an aqueous composition, for example, water.
- the rounded particles comprise rounded sugar particles.
- the rounded particles comprise a suitable solid material which is provided in a rounded particulate form, and which is capable of being adhered to a shell, for example, an uncured elastomer shell, and is capable of being dissolved, for example, using a solvent, thereby leaving open, rounded pores in the shell.
- the rounded particles used in accordance with the invention have a substantially uniform particle size of between about 150 microns and about 1450 microns. More specifically, the particles have a maximum particle size range selected from a group of ranges consisting of (1) a range between about 180 microns and about 425 microns, (2) a range between about 425 microns and about 850 microns, and (3) a range between about 850 microns and about 1450 microns. In one embodiment, about 90% of the particles are in the selected particle size range.
- Another aspect of the invention is a soft prosthetic breast implant, formed by a process comprising the steps of forming a flexible shell of silicone elastomer in the shape of a breast implant, adhering on the exterior of the flexible shell a substantially even distribution of rounded particles, curing the flexible shell with the rounded particles adhered thereto, and exposing the flexible shell to a suitable solvent for a sufficient amount of time to dissolve the rounded particles thereby forming an open-pored structure on the exterior of the flexible shell.
- At least one, for example, at least two, for example all three of the physical properties of ultimate break force, ultimate elongation, and ultimate tensile strength of an implant formed in accordance with the present process is superior to an implant made using substantially the same process and the same materials except for conventional angular or non-rounded salt crystals instead of rounded salt crystals.
- the step of forming the flexible shell may comprise dipping a mandrel into a liquid dispersion of a shell material, or rotational molding.
- the step of forming the flexible shell comprises forming a shell with an opening and the process further includes attaching a patch to cover the opening.
- the patch may be an unvulcanized elastomer and is attached prior to the step of curing.
- the step of forming the flexible shell comprises forming a shell with an opening and the process further includes attaching valve, for example, a one-way valve to cover the opening.
- the rounded salt crystals may comprise sodium chloride.
- FIGS. 1A-1C show several steps in a process of dip-forming the shell of a breast implant prosthesis
- FIG. 2 is a cross-sectional view through one portion of a textured multi-layered breast implant prosthesis shell
- FIG. 3 is a cross-sectional view through one portion of a textured single-layer breast implant prosthesis shell
- FIG. 4 is a magnified view of a sample of rounded salt crystals used in the implant texturing process of the present invention
- FIG. 5 is a magnified view of a sample of cubic salt crystals used in conventional implant texturing processes of the prior art
- FIGS. 6A and 6B are cross-sectional and plan views, respectively, of a textured implant of the prior art
- FIGS. 7A and 7B are cross-sectional and plan views, respectively, of another textured implant of the prior art.
- FIGS. 8A and 8B are cross-sectional and plan views, respectively, of a textured implant in accordance with the present invention.
- the present invention provides a saline- or gel-filled soft implant for prostheses and tissue expanders.
- the implant generally comprises a shell, for example, a silicone elastomer shell, with a textured surface.
- the primary application for such soft implants is to reconstruct or augment the female breast.
- Other potential applications are implants for the buttocks, testes, or calf, among other body regions.
- FIGS. 1A-1C illustrate one process for forming flexible implant shells for implantable prostheses and tissue expanders, involving dipping a suitably shaped mandrel 20 into a silicone elastomer dispersion 22 .
- Many such dispersions are used in the field. Basically they contain a silicone elastomer and a solvent.
- the silicone elastomer is typically polydimethylsiloxane, polydiphenyl-siloxane or some combination of these two elastomers.
- Typical solvents include xylene or trichloromethane.
- Different manufacturers vary the type and amount of the ingredients in the dispersion, the viscosity of the dispersion and the solid content of the dispersion. Nonetheless, the present invention is expected to be adaptable to have utility with a wide variety of silicone rubber dispersions.
- the mandrel 20 is withdrawn from the dispersion and the excess silicone elastomer dispersion is allowed to drain from the mandrel. After the excess dispersion has drained from the mandrel at least a portion of the solvent is allowed to volatilize or evaporate. Normally this is accomplished by flowing air over the coated mandrel at a controlled temperature and humidity. Different manufacturers use various quantities, velocities or directions of air flow and set the temperature and humidity of the air at different values. However, the desired result, driving off the solvent, remains the same.
- a layered structure like most current silicone elastomer shells can be made by sequentially dipping the mandrel in different dispersions. Alternatively, the steps may be repeated in a single dispersion 22 so that the finished product is a single homogenous material or layer. That is, the dipping process may be done in multiple stages or steps, each step adding more material, yet the finished product exhibits no distinct layers and the entire shell wall is homogenous or uniform in composition.
- FIG. 3 illustrates in cross-section a portion of a textured multi-layered implant of the present invention.
- a primary barrier to fluid passage through the shell wall is provided by an inner barrier layer 30 .
- Two base coat layers 32 , 34 lie radially inward from the barrier layer 30 . In some cases a single base coat layer may be used.
- On the outer side of the barrier layer 30 three further base coat layers 36 , 38 , 40 are provided, although again a single outer layer may be used.
- a tack coat layer 42 outside of the outer base coat layers 30 - 40 , a tack coat layer 42 , a layer of textured crystals 44 , and an overcoat layer 48 are provided.
- the absolute thickness of the implant wall may vary but an exemplary average thickness is about 0.456 mm (0.018 inches).
- the overall thickness of the textured implant wall is somewhat greater than a similar smooth-walled shell because of the extra layers.
- FIG. 3 illustrates a cross-section of textured single-layered implant shell wall 50 that is a homogeneous silicone elastomer made entirely of a barrier material that sterically retards permeation of the silicone gel through the shell.
- the outer surface 52 of the barrier layer 50 is textured.
- the implants made with the single layer 50 may be for implant in the breast such that the entire flexible outer shell is shaped accordingly, for instance in with a more flattened posterior side and rounded anterior side.
- the flexible shell for the prosthetic implant may be formed using a molding process.
- a rotational molding process such as described in Schuessler, U.S. Pat. No. 6,602,452, may be used.
- the process for forming texturing on the exterior surface is preferably done using a dipping technique, but the formation of the flexible shell may then be accomplished by one of a number of methods.
- the flexible shell prior to the texturing process.
- the dip molding process advantageously results in the flexible shell pre-mounted on a dipping mandrel, which can then be used for the texturing process.
- the flexible shell is made by another technique, such as by rotational molding, it can subsequently be mounted on a dipping mandrel and the process continued in the same manner.
- any loose fibers or particles are blown off of the exterior of the shell with an anti-static air gun.
- a tack coat layer is then applied.
- the tack coat layer may be sprayed on, or may be applied by dipping the flexible shell on the mandrel into a tack coat material, for example, a tack coat dispersion.
- the operator immerses the flexible shell into the dispersion and returns the mandrel to a rack for stabilization.
- the time required for stabilization typically varies between about 5 and about 20 minutes.
- a suitable tack coat layer may be made using the same material employed in the base layers.
- rounded salt particles are applied substantially evenly over the entire surface.
- the solid particles may be applied manually by sprinkling them over the surface while the mandrel is manipulated, or a machine operating like a bead blaster or sand blaster could be used to deliver a steady stream of solid particles at an adequate velocity to the coating on the mandrel.
- the coated mandrel is dipped into a body of the particles.
- particle application is accomplished by exposing the coated mandrel to a liquid dispersion of the particles. It should be understood that the present invention is not intended to be restricted to any one particular method of applying the particles.
- a salt bath for coating the tacky flexible shells is prepared by first procuring a quantity of rounded salt crystals and sorting the crystals into a desired size range. For example, unsorted rounded salt crystals are placed in a shaker having a first sieve size (e.g. coarse sieve) and a second sieve size (e.g. fine sieve). Larger salt crystals will be stopped by the coarse sieve at the inlet of the salt shaker, while smaller salt crystals will continue through both of the sieves. Crystals in the desired size range are trapped between the sieves.
- the first sieve is a 14 mesh sieve and the second sieve is a 20 mesh sieve.
- the first sieve is a 20 mesh sieve and the second sieve is a 40 mesh sieve.
- the first sieve is a 40 mesh sieve and the second sieve is a 80 mesh sieve.
- the rounded particles used in accordance with the invention have a substantially uniform particle size of between about 150 microns and about 1450 microns.
- the rounded particles comprise or consist of relatively fine grained particles.
- the rounded particles have a maximum particle size of at least about 150 microns, for example, the particles have a maximum particle size in a range of between about 180 microns and about 425 microns. For example, about 90% of the rounded particles will be retained between a sieve having mesh size 80 and a sieve having mesh size 40.
- the rounded particles comprise or consist of relatively medium grained particles.
- the rounded particles have a maximum particle size of at least about 300 microns, for example, the particles have a maximum particle size in a range of between about 425 microns and about 850 microns. For example, about 90% of the particles will be retained between a sieve having mesh size 40 and a sieve having mesh size 20.
- the rounded particles comprise or consist of relatively large grained particles.
- the rounded particles have a maximum particle size of at least about 800 microns, for example, the particles have a maximum particle size in a range of between about 850 microns and about 1450 microns. For example, about 90% of the particles will be retained between a sieve having mesh size 20 and a sieve having mesh size 14.
- the size of the salt crystals can be selected by sorting a bulk quantity of rounded salt crystals using a series of gradually smaller meshes.
- the salt crystals for example, those having a particular size distribution are then added to an aqueous salt bath prior to being applied to the shell.
- the tacky flexible shells are immersed in the salt bath, rotated for even coverage, removed, and then allowed to stabilize. After a suitable period of stabilization, such as between about 5 minutes and about 20 minutes, the flexible shells may be dipped into an overcoat dispersion.
- a suitable overcoat dispersion may also be made using the same material employed in the base layers.
- the flexible shells on the mandrels are then mounted on a rack and allowed to volatilize for a sufficient time, such as, for example, about 15 minutes.
- the entire silicone elastomer shell structure is vulcanized or cured in an oven at elevated temperatures.
- the temperature of the oven is maintained at a temperature between about 200° F. and about 350° F. for a curing time preferably between about 20 minutes and about 1 hour, 40 minutes.
- the mandrel/shell assembly Upon removal from the oven, the mandrel/shell assembly is placed in a solvent for the solid particles, and the solid particles are allowed to dissolve.
- the solvent is a material that does not affect the structure or integrity of the silicone elastomer.
- the assembly is removed from the solvent and the solvent evaporated.
- the shell is then removed from the mandrel. At this point, it is preferable to place the shell in a solvent for the solid particles and gently agitate it to ensure complete dissolution of all the solid particles. Once the shell has been removed from the solvent, the solvent evaporates or otherwise is removed from the shell.
- Dissolving the solid particles leaves behind open pores, voids or spaces in the surface of the shell. When applied, some of the solid particles are partially exposed so that they can be acted upon by the solvent. These exposed solid particles also provide a way for the solvent to reach those solid particles beneath the surface to dissolve them in turn. The result is an interconnected structure of cells, some of which are open to the surface, in the outer layer of the shell.
- the process described above produces a shell like that shown in either FIG. 2 or 3 .
- the shell has a thin outer wall made of silicone elastomer with an opening therein at the point where a support member connected to the mandrel 20 , which opening will subsequently be covered with a patch.
- the present invention diverges from previous processes in the make-up of the salt crystals used in the dispersion 22 . Namely, as seen in FIG. 4 , rounded salt crystals 60 are shown over a reference scale 62 . In contrast to regular crystalline sodium chloride 70 , as seen against a scale 72 in FIG. 5 , the rounded salt crystals 60 have been appropriately processed to smooth any sharp or non-rounded edges that are typically found on standard sodium chloride crystals 70 (sometimes, termed “cubic salt crystals”).
- FIGS. 6A and 6B illustrate in magnified cross-section and plan view, respectively, an implant shell 80 of the prior art having texturing formed using conventional cubic salt crystals.
- the shell 80 includes an inner wall 82 and an outer textured surface 84 .
- This textured surface 84 is formed by applying cubic salt crystals and then dissolving those crystals to leave an open-celled porous surface.
- the relatively rough surface 84 is partly the result of the angular salt crystals used in the formation process.
- the particular texture illustrated is sold under the tradename Biocell® surface texture by Allergan, Inc. of Irvine, Calif.
- FIGS. 7A and 7B illustrate in magnified cross-section and plan view, respectively, another implant shell 90 of the prior art having texturing formed using conventional cubic salt crystals.
- the shell 90 includes an inner wall 92 and an outer textured surface 94 .
- This textured surface 94 is formed by an embossing process that imprints the texture on uncured silicone material.
- the particular texture illustrated is sold under the tradename Siltex® surface texture by Mentor Corp. of Santa Barbara, Calif.
- FIGS. 8A and 8B a magnified cross-section and plan view of an implant shell 100 of the present invention having texturing formed using rounded salt crystals is illustrated.
- the shell 100 includes an inner wall 102 and an outer textured surface 104 .
- This textured surface 104 is formed by applying rounded salt crystals and then dissolving those crystals to leave an open-celled, porous, textured surface, as explained above.
- the textured surface 104 is somewhat smoother than those made with angular salt crystals, as seen in FIGS. 6 and 7 .
- the pores or openings in the open-celled surface 104 have smoother dividing walls and fewer angular discontinuities than the pores or openings in conventionally manufactured shells that are otherwise identical but use angular salt crystals rather than rounded salt crystals. As will be shown, this difference surprisingly leads to statistically significant changes in overall shell strength.
- the rounded salt crystals are applied so as to achieve a depth ranging from a portion of one crystal diameter to a multiple of many crystal diameters.
- the crystals may be embedded in the surface of the shell to a depth of from about one to about three times the diameter of the crystals.
- Penetration of the solid crystals depends upon the size of the crystals, the thickness of the final uncured layer, the viscosity of the uncured layer and the force with which the crystals are applied. These parameters can be controlled to achieve a desired depth of penetration. For example, if the last layer is relatively thick and low in viscosity, less external force will be required on the solid crystals to produce an acceptable pore depth.
- salts may be suitable based on several factors: (1) the salt should be economically available in the desired particle sizes; (2) the salt should be nontoxic in case some remains in the surface of the prosthesis; and (3) the salt should be readily soluble in a solvent that is economically available, nontoxic and does not dissolve the silicone elastomer.
- the rounded salt particles are sodium chloride crystals which are readily available in granulated form, and can be processed into round crystals, for example, by an industrial milling facility, including Central Salt & Marine Chemicals Research Institute of Bhavnagar, India, a subsidiary of the Council of Scientific & Industrial Research (CSIR), a publicly funded industrial R&D organization in India.
- the solvent may comprise pure water.
- the opening left by the dip molding process may be patched with unvulcanized sheeting, for example, uncured silicone elastomer sheeting.
- the prosthesis is to be filled with silicone gel, this gel may be added and cured, the filled prosthesis packaged, and the packaged prosthesis sterilized.
- the prosthesis is to be inflated with a saline solution, a one-way valve is assembled and installed, the prosthesis is post cured if required, and the prosthesis is then cleaned, packaged and sterilized.
- a combination breast implant prosthesis can also be made wherein a gel-filled sac is positioned inside the shell to be surrounded by saline solution.
- an implant shell having a texture formed with round salt crystals are statistically superior to those formed using cubic salt crystals. This is believed to be due to a reduction in stress concentrations, which may be seen at the sharp corners formed using cubic salt crystals.
- BIOCELL® Saline- or Silicone-Filled Breast Implants by Allergan, Inc. of Irvine, Calif. More specifically, random BIOCELL® shells formed using the process described with reference to FIGS. 6A and 6B were used for comparison. Sixty specimens from this group were cut using an H2 die and tested for tensile strength. Table I below illustrates the results.
- test samples of similar thickness formed by the methods of the present invention experience lower stresses during elongation while the break force, ultimate elongation, and tensile strengths are significantly higher.
- the mean thickness of the test samples formed in accordance with present invention was 0.0214 inches, while the mean thickness of the prior art test samples was 0.0209 inches, or around a 2.3% difference.
- the mean ultimate break force for samples of the present invention was more than 5% greater, the mean ultimate elongation was more than 6% greater, and the mean ultimate tensile strength was nearly 3% greater than samples of the prior art.
- the resulting 662% mean elongation for the sixty shells tested is well past the level required by various regulatory bodies around the word.
- the U.S. standard is 350% from ASTM F703, Standard Specification for Implantable Breast Prostheses.
- the standard for elongation is set at 450% by ISO 14607.
- the implant shells formed by the lost material technique and rounded salt crystals satisfy these standards with greater margins of confidence than ever before. It is believed that changing from a cubic crystal with sharp corners and edges to the rounded crystals where stress concentrations are more evenly distributed helps statistically meet consensus performance breast standards.
- test samples of similar thickness formed by the methods of the present invention experience lower stresses during elongation while the break force, ultimate elongation, and tensile strengths are significantly higher.
- the mean thickness of the test samples formed in accordance with present invention was 0.0196 inches, while the mean thickness of the prior art test samples was 0.0197 inches, or around a 0.05% difference, with the samples made in accordance with the present invention being thinner on average.
- the mean ultimate break force for samples of the present invention was more than 5% greater
- the mean ultimate elongation was more than 3% greater (and sufficient to meet global standards)
- the mean ultimate tensile strength was nearly 6% greater than samples of the prior art.
- the test results indicate a non-linear relationship relative to the difference in thickness.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
A method of texturing a soft prosthetic implant shell, such as a silicone breast implant shell. A soft prosthetic implant with a textured external surface layer of silicone elastomer and having an open-cell structure is made by adhering and then dissolving round salt crystals. The resulting roughened surface has enhanced physical properties relative to surfaces formed with angular salt crystals. An implant having such a textured external surface layer is expected to help prevent capsular contraction, to help prevent scar formation, and to help in anchoring the implant within the body.
Description
- This application is a divisional of U.S. patent application Ser. No. 12/261,939, filed Oct. 30, 2008, which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/985,489, filed on Nov. 5, 2007 and U.S. Provisional Patent Application Ser. No. 60/991,004, filed on Nov. 29, 2007, the disclosure of each of these three applications incorporated in its entirety by this reference.
- The present invention relates to soft prosthetic implants and, more particularly, to methods of texturing the exterior surface of such implants, for instance breast implants, to produce an open-cell texture on the outer surface.
- Implantable prostheses are commonly used to replace or augment body tissue. In the case of breast cancer, it is sometimes necessary to remove some or all of the mammary gland and surrounding tissue, which creates a void that can be filled with an implantable prosthesis. The implant serves to support surrounding tissue and to maintain the appearance of the body. The restoration of the normal appearance of the body has an extremely beneficial psychological effect on post-operative patients, eliminating much of the shock and depression that often follows extensive surgical procedures. Implantable prostheses are also used more generally for restoring the normal appearance of soft tissue in various areas of the body, such as the buttocks, chin, calf, etc.
- Soft implantable prostheses typically include a relatively thin and quite flexible envelope or shell made of vulcanized (cured) silicone elastomer. The shell is filled either with a silicone gel or with a normal saline solution. The filling of the shell takes place before or after the shell is inserted through an incision in the patient.
- The development of implants having textured outer surfaces reflects an attempt to prevent the contraction of the fibrous outer capsule that forms around the implant, which tends to render an implant spherical, painful and aesthetically undesirable. Layers of polyether, polyester or polyurethane foam material have been applied to the back sides of mammary prostheses so that fibrous-tissue could grow into the material and thereby anchor prosthesis securely to the chest wall. However, possible problems exist with foam materials, which may degrade in the body over a period of time, and the effectiveness of these materials for preventing capsular contracture may disappear as they degrade.
- Despite many advances in the construction of soft prosthetic implants, there remains a need for better methods for texturing surfaces of implants.
- The present invention provides processes for forming soft prosthetic implants having textured surfaces and implants formed by said processes. The processes generally comprise the steps of forming a flexible shell, adhering on the exterior of the flexible shell a distribution of rounded particles, curing the flexible shell with the rounded particles adhered thereto, and causing or allowing the rounded particles to be removed from the shell thereby leaving impressions of the particles in the shell to create an open-pored structure on a surface thereof.
- In one embodiment, the flexible shell is formed of a silicone elastomer. For instance, the flexible shell may be formed of a plurality of layers of different silicone elastomers, or the flexible shell may be formed of a single homogeneous layer of a silicone elastomer.
- The step of forming the flexible shell may comprise dipping a mandrel into a liquid dispersion of elastomeric material. Alternatively, the step of forming comprises rotational molding.
- In one embodiment, the step of adhering comprises dipping the flexible shell into a liquid containing the rounded particles, for example, a liquid dispersion or emulsion of rounded particles, for example, rounded salt crystals. Prior to the step of dipping the flexible shell, the process may also include applying a tack coat layer onto the flexible shell.
- In one aspect, the rounded particles comprise rounded crystals of sodium chloride and the solvent is an aqueous composition, for example, water. In other embodiments, the rounded particles comprise rounded sugar particles. In other embodiments, the rounded particles comprise a suitable solid material which is provided in a rounded particulate form, and which is capable of being adhered to a shell, for example, an uncured elastomer shell, and is capable of being dissolved, for example, using a solvent, thereby leaving open, rounded pores in the shell.
- In one embodiment, the rounded particles used in accordance with the invention have a substantially uniform particle size of between about 150 microns and about 1450 microns. More specifically, the particles have a maximum particle size range selected from a group of ranges consisting of (1) a range between about 180 microns and about 425 microns, (2) a range between about 425 microns and about 850 microns, and (3) a range between about 850 microns and about 1450 microns. In one embodiment, about 90% of the particles are in the selected particle size range.
- Another aspect of the invention is a soft prosthetic breast implant, formed by a process comprising the steps of forming a flexible shell of silicone elastomer in the shape of a breast implant, adhering on the exterior of the flexible shell a substantially even distribution of rounded particles, curing the flexible shell with the rounded particles adhered thereto, and exposing the flexible shell to a suitable solvent for a sufficient amount of time to dissolve the rounded particles thereby forming an open-pored structure on the exterior of the flexible shell.
- In one embodiment, at least one, for example, at least two, for example all three of the physical properties of ultimate break force, ultimate elongation, and ultimate tensile strength of an implant formed in accordance with the present process is superior to an implant made using substantially the same process and the same materials except for conventional angular or non-rounded salt crystals instead of rounded salt crystals.
- The step of forming the flexible shell may comprise dipping a mandrel into a liquid dispersion of a shell material, or rotational molding. In one embodiment, the step of forming the flexible shell comprises forming a shell with an opening and the process further includes attaching a patch to cover the opening. The patch may be an unvulcanized elastomer and is attached prior to the step of curing. Alternatively, the step of forming the flexible shell comprises forming a shell with an opening and the process further includes attaching valve, for example, a one-way valve to cover the opening. The rounded salt crystals may comprise sodium chloride.
- A further understanding of the nature and advantages of the present invention are set forth in the following description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.
- Features and advantages of the present invention will become appreciated and the same become better understood with reference to the specification, claims, and appended drawings wherein:
-
FIGS. 1A-1C show several steps in a process of dip-forming the shell of a breast implant prosthesis; -
FIG. 2 is a cross-sectional view through one portion of a textured multi-layered breast implant prosthesis shell; -
FIG. 3 is a cross-sectional view through one portion of a textured single-layer breast implant prosthesis shell; -
FIG. 4 is a magnified view of a sample of rounded salt crystals used in the implant texturing process of the present invention; -
FIG. 5 is a magnified view of a sample of cubic salt crystals used in conventional implant texturing processes of the prior art; -
FIGS. 6A and 6B are cross-sectional and plan views, respectively, of a textured implant of the prior art; -
FIGS. 7A and 7B are cross-sectional and plan views, respectively, of another textured implant of the prior art; and -
FIGS. 8A and 8B are cross-sectional and plan views, respectively, of a textured implant in accordance with the present invention. - The present invention provides a saline- or gel-filled soft implant for prostheses and tissue expanders. The implant generally comprises a shell, for example, a silicone elastomer shell, with a textured surface. The primary application for such soft implants is to reconstruct or augment the female breast. Other potential applications are implants for the buttocks, testes, or calf, among other body regions.
-
FIGS. 1A-1C illustrate one process for forming flexible implant shells for implantable prostheses and tissue expanders, involving dipping a suitably shapedmandrel 20 into asilicone elastomer dispersion 22. Many such dispersions are used in the field. Basically they contain a silicone elastomer and a solvent. The silicone elastomer is typically polydimethylsiloxane, polydiphenyl-siloxane or some combination of these two elastomers. Typical solvents include xylene or trichloromethane. Different manufacturers vary the type and amount of the ingredients in the dispersion, the viscosity of the dispersion and the solid content of the dispersion. Nonetheless, the present invention is expected to be adaptable to have utility with a wide variety of silicone rubber dispersions. - The
mandrel 20 is withdrawn from the dispersion and the excess silicone elastomer dispersion is allowed to drain from the mandrel. After the excess dispersion has drained from the mandrel at least a portion of the solvent is allowed to volatilize or evaporate. Normally this is accomplished by flowing air over the coated mandrel at a controlled temperature and humidity. Different manufacturers use various quantities, velocities or directions of air flow and set the temperature and humidity of the air at different values. However, the desired result, driving off the solvent, remains the same. - It is also common for prostheses manufacturers to repeat this dip and volatilize procedure a number of times so that a number of layers are built up on the mandrel to reach a desired shell thickness. A layered structure like most current silicone elastomer shells can be made by sequentially dipping the mandrel in different dispersions. Alternatively, the steps may be repeated in a
single dispersion 22 so that the finished product is a single homogenous material or layer. That is, the dipping process may be done in multiple stages or steps, each step adding more material, yet the finished product exhibits no distinct layers and the entire shell wall is homogenous or uniform in composition. -
FIG. 3 illustrates in cross-section a portion of a textured multi-layered implant of the present invention. A primary barrier to fluid passage through the shell wall is provided by aninner barrier layer 30. Two base coat layers 32, 34 lie radially inward from thebarrier layer 30. In some cases a single base coat layer may be used. On the outer side of thebarrier layer 30, three further base coat layers 36, 38, 40 are provided, although again a single outer layer may be used. Furthermore, outside of the outer base coat layers 30-40, atack coat layer 42, a layer oftextured crystals 44, and anovercoat layer 48 are provided. The absolute thickness of the implant wall may vary but an exemplary average thickness is about 0.456 mm (0.018 inches). The overall thickness of the textured implant wall is somewhat greater than a similar smooth-walled shell because of the extra layers. - Alternatively,
FIG. 3 illustrates a cross-section of textured single-layeredimplant shell wall 50 that is a homogeneous silicone elastomer made entirely of a barrier material that sterically retards permeation of the silicone gel through the shell. Theouter surface 52 of thebarrier layer 50 is textured. The implants made with thesingle layer 50 may be for implant in the breast such that the entire flexible outer shell is shaped accordingly, for instance in with a more flattened posterior side and rounded anterior side. - In addition to the aforementioned dipping process, the flexible shell for the prosthetic implant may be formed using a molding process. For example, a rotational molding process such as described in Schuessler, U.S. Pat. No. 6,602,452, may be used. The process for forming texturing on the exterior surface is preferably done using a dipping technique, but the formation of the flexible shell may then be accomplished by one of a number of methods.
- An exemplary process for forming a textured outer surface on either a multi-layered shell as in
FIG. 2 or a single-layered shell as inFIG. 3 will now be described. After themandrel 20 ofFIGS. 1A-1C is raised out of the dispersion with what is to be the final layer adhering thereto, this layer is allowed to stabilize. That is, it is held until the final coating no longer flows freely. This occurs as some of the solvent evaporates from the final coating, raising its viscosity. - Again, it should be understood that alternative methods are contemplated for forming the flexible shell prior to the texturing process. The dip molding process advantageously results in the flexible shell pre-mounted on a dipping mandrel, which can then be used for the texturing process. However, if the flexible shell is made by another technique, such as by rotational molding, it can subsequently be mounted on a dipping mandrel and the process continued in the same manner.
- Once the flexible shell has been stabilized and mounted on the mandrel, any loose fibers or particles are blown off of the exterior of the shell with an anti-static air gun. A tack coat layer is then applied. The tack coat layer may be sprayed on, or may be applied by dipping the flexible shell on the mandrel into a tack coat material, for example, a tack coat dispersion. The operator immerses the flexible shell into the dispersion and returns the mandrel to a rack for stabilization. The time required for stabilization typically varies between about 5 and about 20 minutes. A suitable tack coat layer may be made using the same material employed in the base layers.
- After tack coat layer has been applied, rounded salt particles are applied substantially evenly over the entire surface. The solid particles may be applied manually by sprinkling them over the surface while the mandrel is manipulated, or a machine operating like a bead blaster or sand blaster could be used to deliver a steady stream of solid particles at an adequate velocity to the coating on the mandrel.
- In one embodiment, the coated mandrel is dipped into a body of the particles. In another embodiment, particle application is accomplished by exposing the coated mandrel to a liquid dispersion of the particles. It should be understood that the present invention is not intended to be restricted to any one particular method of applying the particles.
- In one embodiment, a salt bath for coating the tacky flexible shells is prepared by first procuring a quantity of rounded salt crystals and sorting the crystals into a desired size range. For example, unsorted rounded salt crystals are placed in a shaker having a first sieve size (e.g. coarse sieve) and a second sieve size (e.g. fine sieve). Larger salt crystals will be stopped by the coarse sieve at the inlet of the salt shaker, while smaller salt crystals will continue through both of the sieves. Crystals in the desired size range are trapped between the sieves. In a specific embodiment, the first sieve is a 14 mesh sieve and the second sieve is a 20 mesh sieve. In another embodiment, the first sieve is a 20 mesh sieve and the second sieve is a 40 mesh sieve. In yet another embodiment, the first sieve is a 40 mesh sieve and the second sieve is a 80 mesh sieve.
- In one embodiment, the rounded particles used in accordance with the invention have a substantially uniform particle size of between about 150 microns and about 1450 microns.
- In one embodiment, the rounded particles comprise or consist of relatively fine grained particles. For example, in one embodiment, the rounded particles have a maximum particle size of at least about 150 microns, for example, the particles have a maximum particle size in a range of between about 180 microns and about 425 microns. For example, about 90% of the rounded particles will be retained between a sieve having
mesh size 80 and a sieve havingmesh size 40. - In another embodiment, the rounded particles comprise or consist of relatively medium grained particles. For example, in one embodiment, the rounded particles have a maximum particle size of at least about 300 microns, for example, the particles have a maximum particle size in a range of between about 425 microns and about 850 microns. For example, about 90% of the particles will be retained between a sieve having
mesh size 40 and a sieve havingmesh size 20. - In yet another embodiment, the rounded particles comprise or consist of relatively large grained particles. For example, in one embodiment, the rounded particles have a maximum particle size of at least about 800 microns, for example, the particles have a maximum particle size in a range of between about 850 microns and about 1450 microns. For example, about 90% of the particles will be retained between a sieve having
mesh size 20 and a sieve having mesh size 14. - The size of the salt crystals can be selected by sorting a bulk quantity of rounded salt crystals using a series of gradually smaller meshes.
- In accordance with one embodiment of the invention, the salt crystals, for example, those having a particular size distribution are then added to an aqueous salt bath prior to being applied to the shell. The tacky flexible shells are immersed in the salt bath, rotated for even coverage, removed, and then allowed to stabilize. After a suitable period of stabilization, such as between about 5 minutes and about 20 minutes, the flexible shells may be dipped into an overcoat dispersion. A suitable overcoat dispersion may also be made using the same material employed in the base layers. The flexible shells on the mandrels are then mounted on a rack and allowed to volatilize for a sufficient time, such as, for example, about 15 minutes.
- In one embodiment, the entire silicone elastomer shell structure is vulcanized or cured in an oven at elevated temperatures. For example, the temperature of the oven is maintained at a temperature between about 200° F. and about 350° F. for a curing time preferably between about 20 minutes and about 1 hour, 40 minutes.
- Upon removal from the oven, the mandrel/shell assembly is placed in a solvent for the solid particles, and the solid particles are allowed to dissolve. The solvent is a material that does not affect the structure or integrity of the silicone elastomer. When the solid particles have dissolved, the assembly is removed from the solvent and the solvent evaporated. The shell is then removed from the mandrel. At this point, it is preferable to place the shell in a solvent for the solid particles and gently agitate it to ensure complete dissolution of all the solid particles. Once the shell has been removed from the solvent, the solvent evaporates or otherwise is removed from the shell.
- Dissolving the solid particles leaves behind open pores, voids or spaces in the surface of the shell. When applied, some of the solid particles are partially exposed so that they can be acted upon by the solvent. These exposed solid particles also provide a way for the solvent to reach those solid particles beneath the surface to dissolve them in turn. The result is an interconnected structure of cells, some of which are open to the surface, in the outer layer of the shell. The process described above produces a shell like that shown in either
FIG. 2 or 3. The shell has a thin outer wall made of silicone elastomer with an opening therein at the point where a support member connected to themandrel 20, which opening will subsequently be covered with a patch. - The present invention diverges from previous processes in the make-up of the salt crystals used in the
dispersion 22. Namely, as seen inFIG. 4 ,rounded salt crystals 60 are shown over areference scale 62. In contrast to regularcrystalline sodium chloride 70, as seen against ascale 72 inFIG. 5 , the roundedsalt crystals 60 have been appropriately processed to smooth any sharp or non-rounded edges that are typically found on standard sodium chloride crystals 70 (sometimes, termed “cubic salt crystals”). -
FIGS. 6A and 6B illustrate in magnified cross-section and plan view, respectively, animplant shell 80 of the prior art having texturing formed using conventional cubic salt crystals. Theshell 80 includes aninner wall 82 and an outertextured surface 84. Thistextured surface 84 is formed by applying cubic salt crystals and then dissolving those crystals to leave an open-celled porous surface. The relativelyrough surface 84 is partly the result of the angular salt crystals used in the formation process. The particular texture illustrated is sold under the tradename Biocell® surface texture by Allergan, Inc. of Irvine, Calif. -
FIGS. 7A and 7B illustrate in magnified cross-section and plan view, respectively, anotherimplant shell 90 of the prior art having texturing formed using conventional cubic salt crystals. Theshell 90 includes aninner wall 92 and an outertextured surface 94. Thistextured surface 94 is formed by an embossing process that imprints the texture on uncured silicone material. The particular texture illustrated is sold under the tradename Siltex® surface texture by Mentor Corp. of Santa Barbara, Calif. - Now with references to
FIGS. 8A and 8B , a magnified cross-section and plan view of animplant shell 100 of the present invention having texturing formed using rounded salt crystals is illustrated. Theshell 100 includes aninner wall 102 and an outertextured surface 104. Thistextured surface 104 is formed by applying rounded salt crystals and then dissolving those crystals to leave an open-celled, porous, textured surface, as explained above. Thetextured surface 104 is somewhat smoother than those made with angular salt crystals, as seen inFIGS. 6 and 7 . Although not shown in great detail, the pores or openings in the open-celled surface 104 have smoother dividing walls and fewer angular discontinuities than the pores or openings in conventionally manufactured shells that are otherwise identical but use angular salt crystals rather than rounded salt crystals. As will be shown, this difference surprisingly leads to statistically significant changes in overall shell strength. - In one embodiment, the rounded salt crystals are applied so as to achieve a depth ranging from a portion of one crystal diameter to a multiple of many crystal diameters. The crystals may be embedded in the surface of the shell to a depth of from about one to about three times the diameter of the crystals. Penetration of the solid crystals depends upon the size of the crystals, the thickness of the final uncured layer, the viscosity of the uncured layer and the force with which the crystals are applied. These parameters can be controlled to achieve a desired depth of penetration. For example, if the last layer is relatively thick and low in viscosity, less external force will be required on the solid crystals to produce an acceptable pore depth.
- Although standard sodium chloride is preferably used for the rounded salt crystals, other salts may be suitable based on several factors: (1) the salt should be economically available in the desired particle sizes; (2) the salt should be nontoxic in case some remains in the surface of the prosthesis; and (3) the salt should be readily soluble in a solvent that is economically available, nontoxic and does not dissolve the silicone elastomer.
- In one embodiment, the rounded salt particles are sodium chloride crystals which are readily available in granulated form, and can be processed into round crystals, for example, by an industrial milling facility, including Central Salt & Marine Chemicals Research Institute of Bhavnagar, India, a subsidiary of the Council of Scientific & Industrial Research (CSIR), a publicly funded industrial R&D organization in India. When crystalline sodium chloride is used in accordance with the invention, the solvent may comprise pure water. A person of ordinary skill in the art will understand that a number of solid and solvent pairs could be chosen in accordance with various embodiments of the invention.
- After finishing the shell according to the steps described above, additional processing steps may be performed. For example, the opening left by the dip molding process may be patched with unvulcanized sheeting, for example, uncured silicone elastomer sheeting. If the prosthesis is to be filled with silicone gel, this gel may be added and cured, the filled prosthesis packaged, and the packaged prosthesis sterilized. If the prosthesis is to be inflated with a saline solution, a one-way valve is assembled and installed, the prosthesis is post cured if required, and the prosthesis is then cleaned, packaged and sterilized. A combination breast implant prosthesis can also be made wherein a gel-filled sac is positioned inside the shell to be surrounded by saline solution.
- As mentioned above, the properties of an implant shell having a texture formed with round salt crystals are statistically superior to those formed using cubic salt crystals. This is believed to be due to a reduction in stress concentrations, which may be seen at the sharp corners formed using cubic salt crystals.
- To compare the different shells, standard tensile strength specimens were cut from the shells and subjected to stress tests. The comparison shell was a standard commercial textured shell of the prior art sold under the tradename INAMED® BIOCELL® Saline- or Silicone-Filled Breast Implants, by Allergan, Inc. of Irvine, Calif. More specifically, random BIOCELL® shells formed using the process described with reference to
FIGS. 6A and 6B were used for comparison. Sixty specimens from this group were cut using an H2 die and tested for tensile strength. Table I below illustrates the results. -
TABLE I Test of Prior Art Commercial Textured Shells Ultimate Break Ultimate Tensile Thickness Stress@ % elongation (psi) force Elongation Strength (in) 50% 100% 200% 300% (lbf) (%) (psi) Mean 0.0209 52.79 84.40 176.119 295.552 4.272 621.690 819.079 Std. 0.0021 3.54 5.79 11.985 19.723 0.511 32.227 42.482 Min 0.0170 44.49 70.49 147.73 250.188 3.439 552.016 752.760 Max 0.0260 63.89 102.77 213.868 355.503 5.802 707.647 912.512 - Likewise, sixty specimens from a group of shells formed using the process of the present invention were cut using an H2 die and tested for tensile strength. Table II below illustrates the results.
-
TABLE II Test of Shells Produced with Process of the Present Invention Ultimate Break Ultimate Tensile Thickness Stress@ % elongation (psi) force Elongation Strength (in) 50% 100% 200% 300% (lbf) (%) (psi) Mean 0.0214 47.50 76.08 163.350 280.964 4.494 662.411 841.880 Std. 0.0013 2.18 3.74 7.811 12.474 0.328 20.845 33.806 Min 0.0190 42.52 68.33 147.318 252.912 3.617 591.457 761.376 Max 0.0250 52.20 84.29 179.215 305.826 5.528 705.347 934.60 - These data show that test samples of similar thickness formed by the methods of the present invention experience lower stresses during elongation while the break force, ultimate elongation, and tensile strengths are significantly higher. Specifically, the mean thickness of the test samples formed in accordance with present invention was 0.0214 inches, while the mean thickness of the prior art test samples was 0.0209 inches, or around a 2.3% difference. However, the mean ultimate break force for samples of the present invention was more than 5% greater, the mean ultimate elongation was more than 6% greater, and the mean ultimate tensile strength was nearly 3% greater than samples of the prior art. Given the number of samples (n=60), these differences are somewhat surprising given the similar technique for forming the shells and similar thicknesses. Applicants believe that the rounded salt crystals form a smoother open-cell structure on the exterior of the shells which reduces stress concentrations. As such, the test results indicate other than an expected linear relationship proportional to the difference in thickness.
- It is also important to note the improvement in ultimate elongation. The resulting 662% mean elongation for the sixty shells tested is well past the level required by various regulatory bodies around the word. In particular, the U.S. standard is 350% from ASTM F703, Standard Specification for Implantable Breast Prostheses. In Europe and elsewhere, the standard for elongation is set at 450% by ISO 14607. The implant shells formed by the lost material technique and rounded salt crystals satisfy these standards with greater margins of confidence than ever before. It is believed that changing from a cubic crystal with sharp corners and edges to the rounded crystals where stress concentrations are more evenly distributed helps statistically meet consensus performance breast standards.
- In addition, tests were conducted on shells that were formed using the texturing process of the present invention both with conventional cubic salt crystals and with the rounded salt crystals disclosed herein. That is, instead of comparing the shells of the present invention with existing commercial shells, new shells were formed using the same process but with conventional angular or cubic salt crystals.
- Specifically, five shells textured with regular cubic salt crystals were dip molded, and five shells textured with rounded salt crystals were also dip molded. All the shells were subjected to gel curing at 145° C. for 8 hours, and then subjected to a simulated sterilization at 127° C. for 20.5 hours. Sixty tensile strength specimens from each batch were cut with an H2 die and tested. These results are shown in the following Tables III and IV.
-
TABLE III Test of Textured Shells formed with Cubic Salt Crystals Ultimate Break Ultimate Tensile Thickness Stress@ % elongation (psi) force Elongation Strength (in) 100% 200% 300% (lbf) (%) (psi) Mean 0.0197 108.44 245.196 427.548 3.157 574.394 1020.331 Std. 0.0012 4.32 9.455 15.716 0.253 22.905 50.407 Min 0.017 96.59 218.531 396.776 2.73 513.924 905.827 Max 0.022 119.34 270.61 471.472 3.781 616.102 1126.053 -
TABLE IV Test of Textured Shells formed with Rounded Salt Crystals Ultimate Break Ultimate Tensile Thickness Stress@ % elongation (psi) force Elongation Strength (in) 100% 200% 300% (lbf) (%) (psi) Mean 0.0196 113.49 253.224 437.177 3.321 593.298 1076.807 Std. 0.0015 5.13 10.537 16.966 0.337 22.248 57.867 Min 0.015 102.42 232.879 401.088 2.189 543.156 926.505 Max 0.025 124.49 276.015 473.083 4.321 639.847 1181.189 - Again, these data show that test samples of similar thickness formed by the methods of the present invention experience lower stresses during elongation while the break force, ultimate elongation, and tensile strengths are significantly higher. Specifically, the mean thickness of the test samples formed in accordance with present invention was 0.0196 inches, while the mean thickness of the prior art test samples was 0.0197 inches, or around a 0.05% difference, with the samples made in accordance with the present invention being thinner on average. However, the mean ultimate break force for samples of the present invention was more than 5% greater, the mean ultimate elongation was more than 3% greater (and sufficient to meet global standards), and the mean ultimate tensile strength was nearly 6% greater than samples of the prior art. Given the number of samples (n=60) and the fact that the shells were identically formed except for the shape of the salt crystals, these differences are even more surprising than the previous comparison. Once again, the test results indicate a non-linear relationship relative to the difference in thickness.
- Although the invention has been described and illustrated with a certain degree of particularity, it is understood that the present disclosure has been made only by way of example, and that numerous changes in the combination and arrangement of parts can be resorted to by those skilled in the art without departing from the scope of the invention, as hereinafter claimed.
Claims (12)
1. A process for forming a soft prosthetic implant, comprising:
forming a flexible shell;
adhering on the exterior of the flexible shell a substantially even distribution of rounded salt particles;
curing the flexible shell with the rounded salt particles adhered thereto; and
exposing the flexible shell to an aqueous solvent for the rounded salt particles for a sufficient amount of time to dissolve the rounded salt particles and form an open-pored structure on the exterior of the flexible shell.
2. The process of claim 1 , wherein the rounded salt particles are sodium chloride crystals.
3. The process of claim 1 , wherein the flexible shell is formed of a silicone elastomer.
4. The process of claim 1 further comprising the step of applying a tack coat layer to the flexible shell prior to the step of adhering.
5. The process of claim 1 , further comprising the step of applying an overcoat to the distribution of rounded salt particles prior to the step of curing.
6. The process of claim 1 , wherein the rounded salt particles have a maximum particle size range selected from a group of ranges consisting of (1) a range between about 180 microns and about 425 microns, (2) a range between about 425 microns and about 850 microns, and (3) a range between about 850 microns and about 1450 microns.
7. The process of claim 6 wherein about 90% of the rounded salt particles are in the selected particle size range.
8. The process of claim 1 , wherein the prosthetic implant is a breast implant and the flexible shell is shaped accordingly.
9. The process of claim 1 , wherein the step of forming the flexible shell comprises dipping a mandrel into a liquid dispersion of an elastomeric material.
10. The process of claim 1 , wherein the step of forming the flexible shell comprises rotationally molding the shell.
11. The process of claim 1 , wherein the step of adhering comprises dipping the flexible shell into a liquid containing the rounded salt particles.
12. The process of claim 11 , further comprising the step of applying a tack coat layer onto the flexible shell prior to the step of dipping the flexible shell into a liquid containing the rounded salt particles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/010,929 US20110117267A1 (en) | 2007-11-05 | 2011-01-21 | Soft Prosthesis Shell Texturing Method |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98548907P | 2007-11-05 | 2007-11-05 | |
US99100407P | 2007-11-29 | 2007-11-29 | |
US12/261,939 US8313527B2 (en) | 2007-11-05 | 2008-10-30 | Soft prosthesis shell texturing method |
US13/010,929 US20110117267A1 (en) | 2007-11-05 | 2011-01-21 | Soft Prosthesis Shell Texturing Method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/261,939 Division US8313527B2 (en) | 2007-11-05 | 2008-10-30 | Soft prosthesis shell texturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110117267A1 true US20110117267A1 (en) | 2011-05-19 |
Family
ID=40588926
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/261,939 Active US8313527B2 (en) | 2007-11-05 | 2008-10-30 | Soft prosthesis shell texturing method |
US13/010,929 Abandoned US20110117267A1 (en) | 2007-11-05 | 2011-01-21 | Soft Prosthesis Shell Texturing Method |
US13/659,803 Active 2029-03-30 US9138310B2 (en) | 2007-11-05 | 2012-10-24 | Soft prosthesis shell texturing method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/261,939 Active US8313527B2 (en) | 2007-11-05 | 2008-10-30 | Soft prosthesis shell texturing method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/659,803 Active 2029-03-30 US9138310B2 (en) | 2007-11-05 | 2012-10-24 | Soft prosthesis shell texturing method |
Country Status (5)
Country | Link |
---|---|
US (3) | US8313527B2 (en) |
EP (2) | EP3552581A1 (en) |
CA (1) | CA2704697C (en) |
ES (1) | ES2728400T3 (en) |
WO (1) | WO2009061672A1 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110196489A1 (en) * | 2010-02-05 | 2011-08-11 | Allergan, Inc. | Biocompatible structures and compositions |
US20120245685A1 (en) * | 2009-11-19 | 2012-09-27 | Won Seok Yu | Artificial breast implant provided on the surface threof with silicon open cell foam layer, and method for producing the same |
US8506627B2 (en) | 2008-08-13 | 2013-08-13 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US8546458B2 (en) | 2010-12-07 | 2013-10-01 | Allergan, Inc. | Process for texturing materials |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
US8679570B2 (en) | 2010-04-27 | 2014-03-25 | Allergan, Inc. | Foam-like materials and methods for producing same |
US8685296B2 (en) | 2010-05-11 | 2014-04-01 | Allergan, Inc. | Porogen compositions, method of making and uses |
US8801782B2 (en) | 2011-12-15 | 2014-08-12 | Allergan, Inc. | Surgical methods for breast reconstruction or augmentation |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8889751B2 (en) | 2010-09-28 | 2014-11-18 | Allergan, Inc. | Porous materials, methods of making and uses |
US8951596B2 (en) | 2009-10-16 | 2015-02-10 | Allergan, Inc. | Implants and methods for manufacturing same |
US9044897B2 (en) | 2010-09-28 | 2015-06-02 | Allergan, Inc. | Porous materials, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US9138308B2 (en) | 2010-02-03 | 2015-09-22 | Apollo Endosurgery, Inc. | Mucosal tissue adhesion via textured surface |
US9138310B2 (en) | 2007-11-05 | 2015-09-22 | Allergan, Inc. | Soft prosthesis shell texturing method |
US9539086B2 (en) | 2014-05-16 | 2017-01-10 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US9688006B2 (en) | 2012-12-13 | 2017-06-27 | Allergan, Inc. | Device and method for making a variable surface breast implant |
WO2017205835A1 (en) * | 2016-05-26 | 2017-11-30 | Allergan, Inc. | Production of rounded salt particles |
US9848972B2 (en) | 2008-08-13 | 2017-12-26 | Allergan, Inc. | Dual plane breast implant |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
US10624997B2 (en) | 2010-02-05 | 2020-04-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8690943B2 (en) | 2008-08-20 | 2014-04-08 | Allergan, Inc. | Self-sealing shell for inflatable prostheses |
US8632843B2 (en) * | 2008-11-24 | 2014-01-21 | Promimic Ab | Methods and systems of controlled coating of nanoparticles onto micro-rough implant surfaces and associated implants |
US20100249924A1 (en) | 2009-03-27 | 2010-09-30 | Allergan, Inc. | Bioerodible matrix for tissue involvement |
CA2761902C (en) * | 2009-05-13 | 2019-03-05 | Allergan, Inc. | Implants and methods for manufacturing same |
US8986377B2 (en) | 2009-07-21 | 2015-03-24 | Lifecell Corporation | Graft materials for surgical breast procedures |
FR2952806B1 (en) | 2009-11-20 | 2012-08-10 | Thierry Brinon | IMPLANT FOR ANATOMICAL RECONSTRUCTION OR VOLUMETRIC INCREASE |
CA2787824A1 (en) * | 2010-01-28 | 2011-08-04 | Allergan, Inc. | Open celled foams, implants including them and processes for making same |
US20110196488A1 (en) * | 2010-02-03 | 2011-08-11 | Allergan, Inc. | Degradation resistant implantable materials and methods |
NZ601664A (en) * | 2010-02-05 | 2014-08-29 | Allergan Inc | Inflatable prostheses and methods of making same |
US8636797B2 (en) * | 2010-02-05 | 2014-01-28 | Allergan, Inc. | Inflatable prostheses and methods of making same |
US20120101574A1 (en) * | 2010-08-20 | 2012-04-26 | Allergan, Inc. | Implantable materials |
KR101288115B1 (en) * | 2011-05-04 | 2013-07-19 | 유원석 | Biodegradable polymer-coated silicon implant material and its manufacturing method |
ES2812281T3 (en) | 2012-01-13 | 2021-03-16 | Lifecell Corp | Methods for manufacturing breast prostheses |
ES2647979T3 (en) | 2012-06-21 | 2017-12-27 | Lifecell Corporation | Implantable prosthesis that has acellular tissue fixations |
US20140005783A1 (en) * | 2012-06-29 | 2014-01-02 | Allergan, Inc. | Textured prosthesis with reduced capsular contracture response |
WO2014040649A1 (en) | 2012-09-17 | 2014-03-20 | Phonak Ag | Cic hearing aid seal and method of manufacturing the same |
US10820984B2 (en) | 2012-11-14 | 2020-11-03 | ImplantADJUST, LLC | Implant with elastomeric membrane and methods of fabrication thereof |
JP6408142B2 (en) * | 2014-09-30 | 2018-10-17 | アントニオ・サンブッセティAntonio SAMBUSSETI | Orthotopic artificial endovesical prosthesis |
MX2017003820A (en) * | 2014-09-30 | 2017-10-20 | sambusseti Antonio | Orthotopic artificial bladder endoprosthesis. |
US20160130690A1 (en) * | 2014-11-12 | 2016-05-12 | Applied Silicone Corporation | Immersion Curing Process |
WO2016186803A1 (en) | 2015-05-15 | 2016-11-24 | Lifecell Corporation | Tissue matrices for plastic surgery |
USD752739S1 (en) * | 2015-08-13 | 2016-03-29 | Robert G. Anderson | Tabbed prosthesis insertion bellow |
US10842612B2 (en) | 2015-08-21 | 2020-11-24 | Lifecell Corporation | Breast treatment device |
USD776806S1 (en) * | 2015-10-08 | 2017-01-17 | Robert G. Anderson | Joined universal bellow |
USD773652S1 (en) * | 2015-10-28 | 2016-12-06 | Robert G. Anderson | Inverted bellow |
GB201521474D0 (en) * | 2015-12-04 | 2016-01-20 | Univ Manchester | Textured surfaces for implants |
USD775725S1 (en) * | 2016-05-11 | 2017-01-03 | Robert G. Anderson | Dual chamber prosthesis insertion device |
WO2018045103A1 (en) * | 2016-08-30 | 2018-03-08 | Allergan, Inc. | Method of manufacturing coated beads |
RU2749991C2 (en) | 2016-08-31 | 2021-06-21 | Лайфселл Корпорейшн | Device for mammary gland correction |
US10898313B2 (en) | 2018-08-10 | 2021-01-26 | Mentor Worldwide Llc | Systems, devices and methods of making mammary implants and tissue expanders having ribbed shells |
USD896383S1 (en) | 2018-09-13 | 2020-09-15 | Allergan, Inc. | Tissue expansion device |
CA3112634A1 (en) | 2018-09-13 | 2020-03-19 | Allergan, Inc. | Tissue expansion device |
JP2022507241A (en) | 2018-11-12 | 2022-01-18 | グループ・ピーピーディー・インコーポレイテッド | Porous materials and methods |
US11298220B2 (en) | 2019-05-03 | 2022-04-12 | Lifecell Corporation | Breast treatment device |
USD931460S1 (en) | 2019-08-01 | 2021-09-21 | Mentor Worldwide Llc | Implant shell having internal, global ribs |
USD905855S1 (en) | 2019-08-01 | 2020-12-22 | Mentor Worldwide Llc | Implant shell having internal, circumferential ribs |
USD930834S1 (en) * | 2019-12-10 | 2021-09-14 | David Scott Nutter | Anatomic great toe joint |
US11471268B2 (en) | 2020-04-25 | 2022-10-18 | Mentor Worldwide Llc | Implants having gel zones with higher levels of cohesiveness for eschewing scalloping, dimpling, and wrinkling |
NL2027599B1 (en) | 2021-02-19 | 2022-09-19 | Instructure Labs B V | Biocompatible polymeric implant material having a textured surface |
Citations (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3189921A (en) * | 1962-04-11 | 1965-06-22 | William J Pangman | Compound prosthesis |
US3366975A (en) * | 1965-06-04 | 1968-02-06 | William J. Pangman | Compound prosthesis |
US3559214A (en) * | 1968-10-17 | 1971-02-02 | William J Pangman | Compound prosthesis |
US3665520A (en) * | 1970-10-07 | 1972-05-30 | Medical Eng Corp | Surgically implantable breast prosthesis |
US3934274A (en) * | 1974-10-29 | 1976-01-27 | Hartley Jr John H | Deflatable mammary augmentation prosthesis |
US4157085A (en) * | 1978-03-24 | 1979-06-05 | Dow Corning Corporation | Surgically implantable tissue expanding device and the method of its use |
US4264990A (en) * | 1979-01-24 | 1981-05-05 | Hamas Robert S | Mammary prosthesis |
US4329385A (en) * | 1980-12-19 | 1982-05-11 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Texturing polymer surfaces by transfer casting |
US4428082A (en) * | 1980-12-08 | 1984-01-31 | Naficy Sadeque S | Breast prosthesis with filling valve |
US4433440A (en) * | 1979-02-26 | 1984-02-28 | Cohen I Kelman | Prosthesis formed by inner and outer inflatable containers |
US4482577A (en) * | 1980-12-16 | 1984-11-13 | Albert Goldstein | Coating process of elastomeric material |
US4499211A (en) * | 1981-07-28 | 1985-02-12 | Hoechst Aktiengesellschaft | Open-cell/microporous molded article |
US4573999A (en) * | 1983-10-14 | 1986-03-04 | Netto Daniel J | Human breast prosthesis |
US4592755A (en) * | 1985-06-11 | 1986-06-03 | Ethyl Corporation | Mammary implant |
US4636213A (en) * | 1985-01-24 | 1987-01-13 | Pakiam Anthony I | Implantable prosthesis |
US4643733A (en) * | 1983-04-04 | 1987-02-17 | Hilton Becker | Permanent reconstruction implant and method of performing human tissue expansion |
US4648880A (en) * | 1984-08-30 | 1987-03-10 | Daniel Brauman | Implantable prosthetic devices |
US4650487A (en) * | 1980-10-27 | 1987-03-17 | Memorial Hospital For Cancer And Allied Diseases | Multi-lumen high profile mammary implant |
US4651717A (en) * | 1985-04-04 | 1987-03-24 | Dow Corning Corporation | Multiple envelope tissue expander device |
US4740208A (en) * | 1980-11-21 | 1988-04-26 | Cavon Joseph F | Cast gel implantable prosthesis |
US4795464A (en) * | 1987-02-09 | 1989-01-03 | Tertulin Eberl | Artificial breast |
US4803025A (en) * | 1984-04-23 | 1989-02-07 | Swiss Aluminium Ltd. | Ceramic foam |
US4828560A (en) * | 1988-02-17 | 1989-05-09 | Mcgman Medical Corporation | Spring ring tissue expander |
US4841992A (en) * | 1987-12-17 | 1989-06-27 | Dow Corning Wright Corporation | Tissue expander and method of making and using |
US4889744A (en) * | 1986-11-04 | 1989-12-26 | Medical Products Development Inc. | Method for making open-cell, silicone-elastomer medical implant |
US4899764A (en) * | 1987-12-17 | 1990-02-13 | Dow Corning Wright | Tissue expander and method of making and using |
US4902294A (en) * | 1986-12-03 | 1990-02-20 | Olivier Gosserez | Implantable mammary prosthesis adapted to combat the formation of a retractile shell |
US4906423A (en) * | 1987-10-23 | 1990-03-06 | Dow Corning Wright | Methods for forming porous-surfaced polymeric bodies |
US4936858A (en) * | 1986-07-22 | 1990-06-26 | Keeffe Paul O | Implantable fabric pouch for mammary prosthesis |
US5002572A (en) * | 1986-09-11 | 1991-03-26 | Picha George J | Biological implant with textured surface |
US5007940A (en) * | 1989-06-09 | 1991-04-16 | American Medical Systems, Inc. | Injectable polymeric bodies |
US5007929A (en) * | 1986-11-04 | 1991-04-16 | Medical Products Development, Inc. | Open-cell, silicone-elastomer medical implant |
US5022942A (en) * | 1987-05-27 | 1991-06-11 | Mentor Corporation | Method of making textured surface prosthesis implants |
US5026394A (en) * | 1989-01-10 | 1991-06-25 | Baker James L | Mammary implant |
US5092348A (en) * | 1989-01-17 | 1992-03-03 | Mcghan Medical Corporation | Textured tissue expander |
US5092882A (en) * | 1990-05-04 | 1992-03-03 | Lynn Lawrence A | Multiple compartment breast prosthesis |
US5104409A (en) * | 1989-01-10 | 1992-04-14 | Baker James L | Mammary implant |
US5116387A (en) * | 1989-06-09 | 1992-05-26 | American Medical Systems, Inc. | Preparation of injectable polymeric bodies |
US5185297A (en) * | 1986-09-16 | 1993-02-09 | Lanxide Technology Company, Lp | Ceramic foams |
US5207709A (en) * | 1991-11-13 | 1993-05-04 | Picha George J | Implant with textured surface |
US5282856A (en) * | 1987-12-22 | 1994-02-01 | Ledergerber Walter J | Implantable prosthetic device |
US5296069A (en) * | 1991-12-27 | 1994-03-22 | Silimed-Silicone E. Instrumental Medico Cirurgico E. Hosiptalar Ltda. | Process for manufacturing implants having coated surfaces |
US5480430A (en) * | 1993-06-04 | 1996-01-02 | Mcghan Medical Corporation | Shape-retaining shell for a fluid filled prosthesis |
US5496367A (en) * | 1993-01-13 | 1996-03-05 | Fisher; Jack | Breast implant with baffles |
US5496370A (en) * | 1992-03-13 | 1996-03-05 | Robert S. Hamas | Gel-like prosthetic device |
US5507808A (en) * | 1994-10-26 | 1996-04-16 | Becker; Hilton | Filling tube and seal construction |
US5522896A (en) * | 1989-02-15 | 1996-06-04 | Xomed, Inc. | Biocompatible composite material |
US5525275A (en) * | 1993-07-27 | 1996-06-11 | Pmt Corporation | Method of manufacture of enhanced surface implant |
US5605693A (en) * | 1991-10-18 | 1997-02-25 | Seare, Jr.; William J. | Methods of making a porous device |
US5607473A (en) * | 1994-06-20 | 1997-03-04 | Dr. Helbig GmbH & Co. Orthopadische Produkte KG | Breast prosthesis |
US5630844A (en) * | 1995-06-07 | 1997-05-20 | Novamed Medical Products Manufacturing, Inc. | Biocompatible hydrophobic laminate with thermoplastic elastomer layer |
US5630843A (en) * | 1994-06-30 | 1997-05-20 | Rosenberg; Paul H. | Double chamber tissue expander |
US5855588A (en) * | 1996-10-03 | 1999-01-05 | General Surgical Innovations, Inc. | Combination dissector and expander |
US5871497A (en) * | 1996-10-03 | 1999-02-16 | General Surgical Innovations, Inc. | Combination dissector and expander |
US5895423A (en) * | 1996-02-23 | 1999-04-20 | Coloplast Corporation | Attachable two-chamber breast prosthesis |
US6071309A (en) * | 1995-03-22 | 2000-06-06 | Knowlton; Edward W. | Segmental breast expander for use in breast reconstruction |
US6074421A (en) * | 1997-04-05 | 2000-06-13 | Medisyn Technology, Ltd. | Seamless breast prosthesis |
US6183514B1 (en) * | 1999-08-16 | 2001-02-06 | Hilton Becker | Self positioning breast prosthesis |
US6203570B1 (en) * | 1999-11-24 | 2001-03-20 | John L. Baeke | Breast implant with position lock |
US6206930B1 (en) * | 1998-08-10 | 2001-03-27 | Charlotte-Mecklenburg Hospital Authority | Absorbable tissue expander |
US6214926B1 (en) * | 1999-04-01 | 2001-04-10 | Rhodia Inc. | Silicone membranes formed without the use of 1-1-1 trichloroethane |
US6214045B1 (en) * | 1997-10-10 | 2001-04-10 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US20020038147A1 (en) * | 1999-10-22 | 2002-03-28 | Miller Archibald S. | Breast implant |
US6387133B1 (en) * | 1998-07-16 | 2002-05-14 | Laboratoire Perouse Implant | Reconstruction implant |
US6520989B1 (en) * | 2000-01-18 | 2003-02-18 | Board Of Trustees Of The University Of Arkansas | Extreme volume flexible integrity prosthesis |
US20030036803A1 (en) * | 2001-08-14 | 2003-02-20 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US6531523B1 (en) * | 2000-10-10 | 2003-03-11 | Renal Tech International, Llc | Method of making biocompatible polymeric adsorbing material for purification of physiological fluids of organism |
US6544287B1 (en) * | 1998-12-11 | 2003-04-08 | Gerald W. Johnson | Solid filled implants |
US20030093151A1 (en) * | 2000-12-22 | 2003-05-15 | Guangzhou Wanhe Material Co. Ltd. | Implantable mammary prosthesis with flexible sheet |
US6673285B2 (en) * | 2000-05-12 | 2004-01-06 | The Regents Of The University Of Michigan | Reverse fabrication of porous materials |
US20040010225A1 (en) * | 2001-07-18 | 2004-01-15 | Schuessler David J. | Rotationally molded medical articles |
US6692527B1 (en) * | 1999-12-01 | 2004-02-17 | Howard T. Bellin | Non-rotating breast implant |
US20050055093A1 (en) * | 2003-09-03 | 2005-03-10 | Brennan William A. | System and method for breast augmentation |
US20050070124A1 (en) * | 2003-09-30 | 2005-03-31 | International Business Machines Corporation | Direct photo-patterning of nanoporous organosilicates, and method of use |
US6875233B1 (en) * | 2003-06-10 | 2005-04-05 | Hinging breast implant | |
US6881226B2 (en) * | 1997-10-10 | 2005-04-19 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US20050112169A1 (en) * | 2003-05-21 | 2005-05-26 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US6900055B1 (en) * | 1998-10-28 | 2005-05-31 | Cellon S.A. | Preparation of porous silicone rubber for growing cells or living tissue |
US20060036320A1 (en) * | 2004-08-13 | 2006-02-16 | Keith Job | Spray method for forming shells for prostheses |
US20070093911A1 (en) * | 2003-04-28 | 2007-04-26 | Helmut Fricke | Soft tissue implant such as breast implant, calf muscle implant or the like |
US20070104693A1 (en) * | 2005-11-07 | 2007-05-10 | Quijano Rodolfo C | Breast augmentation system |
US20070104695A1 (en) * | 2005-11-07 | 2007-05-10 | Quijano Rodolfo C | Breast augmentation and reconstruction system |
US20070116735A1 (en) * | 2002-07-31 | 2007-05-24 | Macropore Biosurgery, Inc. | Apparatus and method for preventing adhesions between an implant and surrounding tissues |
US20080009830A1 (en) * | 2006-06-27 | 2008-01-10 | Fujimoto Kazuro L | Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions |
US7323208B2 (en) * | 2004-11-30 | 2008-01-29 | The Regents Of The University Of Michigan | Modified porous materials and method of forming the same |
US20080071371A1 (en) * | 2006-09-20 | 2008-03-20 | Robert Elshout | Texturizing surfaces |
US20080075752A1 (en) * | 2003-10-01 | 2008-03-27 | University Of Washington | Novel Porous Biomaterials |
US20090045166A1 (en) * | 2005-11-11 | 2009-02-19 | Yangyang Li | Method of enhancing biocompatibility of elastomeric materials by microtexturing using microdroplet patterning |
US20090082864A1 (en) * | 2007-09-19 | 2009-03-26 | Gaoyuan Gavin Chen | Naturally contoured, preformed, three dimensional mesh device for breast implant support |
US20090087641A1 (en) * | 2005-11-14 | 2009-04-02 | Favis Basil D | Porous nanosheath networks, method of making and uses thereof |
US20090093878A1 (en) * | 2005-06-28 | 2009-04-09 | Ami Glicksman | Human implantable tissue expander |
US7520896B2 (en) * | 2004-10-28 | 2009-04-21 | Fahd Benslimane | Breast implant, use of an associated pouch, and method for determination of a breast implant |
US20090118829A1 (en) * | 2007-11-05 | 2009-05-07 | Allergan, Inc. | Soft prosthesis shell texturing method |
US7641688B2 (en) * | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
US7645475B2 (en) * | 2004-03-03 | 2010-01-12 | Mentor Corporation | Devices having a textured surface |
US20100042211A1 (en) * | 2008-08-13 | 2010-02-18 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
Family Cites Families (178)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2324735A (en) | 1941-01-16 | 1943-07-20 | Abraham N Spanel | Composite rubber article and method of producing same |
US2805208A (en) | 1952-11-05 | 1957-09-03 | Du Pont | Process for preparing resinous expanded solid |
US3293663A (en) | 1963-08-12 | 1966-12-27 | Dow Corning | Surgically implantable human breast prosthesis |
US3378506A (en) | 1963-10-07 | 1968-04-16 | Dayco Corp | Elastomeric porous material and method for manufacturing same |
US3600718A (en) | 1969-12-29 | 1971-08-24 | Dow Corning | Inflatable prosthesis |
US3700380A (en) | 1970-10-01 | 1972-10-24 | Tecna Corp | Surface or lining compatible with blood or other tissue |
US3852832A (en) | 1972-10-24 | 1974-12-10 | Heyer Schulte Corp | Prosthesis with fixation means |
US4034751A (en) | 1975-11-24 | 1977-07-12 | International Paper Company | Polymeric sheets as synthetic medical dressings or coverings for wounds |
DE2738268A1 (en) | 1977-08-25 | 1979-03-08 | Basf Ag | HYDROPHOBIC POLYURETHANE FOAM FOR OIL ABSORPTION |
US4231979A (en) | 1979-10-12 | 1980-11-04 | Research Corporation | High surface area permeable material |
US4298997A (en) | 1979-10-23 | 1981-11-10 | Rybka F James | Device for inhibiting the formation of fibrous capsular contractures in silicone breast implants and method |
US4470160A (en) | 1980-11-21 | 1984-09-11 | Cavon Joseph F | Cast gel implantable prosthesis |
US4840628A (en) | 1980-11-21 | 1989-06-20 | Cavon Joseph F | Non-enveloped gel prosthesis |
US4298998A (en) | 1980-12-08 | 1981-11-10 | Naficy Sadeque S | Breast prosthesis with biologically absorbable outer container |
US4773909A (en) | 1981-10-06 | 1988-09-27 | Memorial Hospital For Cancer And Allied Diseases | Multi-lumen high profile mammary implant |
US4610690A (en) | 1983-02-22 | 1986-09-09 | Mentor Corporation | Rupture resistant prosthesis with bonded surface layer and method of forming same |
EP0125400B1 (en) | 1983-04-18 | 1987-07-01 | EBERL, Tertulin | Breast prosthesis |
US4531244A (en) | 1983-07-14 | 1985-07-30 | Hamas Robert S | Mammary prosthesis with multiple flow spaces |
US4772285A (en) | 1984-05-09 | 1988-09-20 | The Board Of Trustees Of The Leland Stanford Junior University | Collagen coated soft tissue prostheses |
US4963150B1 (en) | 1984-08-30 | 1994-10-04 | Daniel Brauman | Implantable prosthetic device |
US4584324A (en) | 1984-10-26 | 1986-04-22 | Dow Corning Corporation | Silicone foam, water-based, aerosol composition |
US4944749A (en) | 1985-01-23 | 1990-07-31 | Hilton Becker | Implant and inflating construction |
US4647618A (en) | 1985-05-24 | 1987-03-03 | Dow Corning Corporation | Method of producing a silicone water-based elastomer |
US4608396A (en) | 1985-10-16 | 1986-08-26 | Dow Corning Corporation | Method of producing elastomeric silicone foam |
JPS62231658A (en) | 1985-12-30 | 1987-10-12 | アメリカン・ホスピタル・サプライ・コ−ポレイシヨン | Implantation for breast prosthesis |
US4808558A (en) | 1987-08-26 | 1989-02-28 | Lanxide Technology Company, Lp | Ceramic foams |
CA1322441C (en) | 1986-11-04 | 1993-09-28 | Joel Quaid | Open-cell, silicone-elastomer medical implant and method for making |
US4773908A (en) | 1986-12-18 | 1988-09-27 | Hilton Becker | Filling tube and seal construction for inflatable implant |
US4960425A (en) | 1987-05-27 | 1990-10-02 | Mentor Corporation | Textured surface frosthesis implants |
US4859383A (en) | 1987-06-01 | 1989-08-22 | Bio Med Sciences, Inc. | Process of producing a composite macrostructure of organic and inorganic materials |
US4790848A (en) | 1987-11-27 | 1988-12-13 | Dow Corning Wright | Breast prosthesis with multiple lumens |
US5035249A (en) | 1987-12-17 | 1991-07-30 | Dow Corning Wright Corporation | Method of making envelope for tissue expander |
US4955907A (en) | 1987-12-22 | 1990-09-11 | Ledergerber Walter J | Implantable prosthetic device |
US6228116B1 (en) | 1987-12-22 | 2001-05-08 | Walter J. Ledergerber | Tissue expander |
US4892544A (en) | 1988-03-07 | 1990-01-09 | Dow Corning Wright Corporation | Methods for forming hollow, porous-surfaced elastomeric bodies |
US4950292A (en) | 1988-04-20 | 1990-08-21 | Dow Corning Corporation | Tissue expanders |
FR2630637B1 (en) | 1988-04-27 | 1997-09-12 | Muller Guy Henri | NEW ALVEOLAR PROSTHESIS |
US5219361A (en) | 1988-09-16 | 1993-06-15 | Clemson University | Soft tissue implant with micron-scale surface texture to optimize anchorage |
US5011494A (en) | 1988-09-16 | 1991-04-30 | Clemson University | Soft tissue implant with micron-scale surface texture to optimize anchorage |
US4859712A (en) | 1988-10-12 | 1989-08-22 | Cox-Uphoff International | Silicone foam and method for making it |
US4944750A (en) | 1988-10-12 | 1990-07-31 | Cox-Uphoff International Reel | Composite shell material for prosthesis |
US4955909A (en) | 1989-01-31 | 1990-09-11 | Bioplasty, Inc. | Textured silicone implant prosthesis |
US4969899A (en) | 1989-03-08 | 1990-11-13 | Cox-Uphoff International | Inflatable implant |
US5158573A (en) | 1989-06-09 | 1992-10-27 | American Medical Systems, Inc. | Injectable polymeric bodies |
US4965430A (en) | 1989-09-18 | 1990-10-23 | Dow Corning Wright Corp. | Method of laser machining molds with microtextured surfaces |
US5236453A (en) | 1990-03-09 | 1993-08-17 | Picha George J | Mammary implant and method for reducing capsule contracture |
US5158571A (en) | 1990-03-09 | 1992-10-27 | Picha George J | Tissue expander and method for expanding tissue |
US5147398A (en) | 1990-05-04 | 1992-09-15 | Lynn Lawrence A | Multiple compartment breast prosthesis |
US5128088A (en) | 1990-08-14 | 1992-07-07 | Hollister Incorporated | Continuous method for making adhesive-lined male external catheters |
CA2049377A1 (en) | 1990-09-26 | 1992-03-27 | Donald V. Hillegass | Biocompatible body implant having a textured surface |
US5993716A (en) | 1990-10-19 | 1999-11-30 | Draenert; Klaus | Material and process for its preparation |
US5034422A (en) | 1990-12-19 | 1991-07-23 | Foamex Lp | Low density, high temperature resistant polymeric bodies |
US5348788A (en) | 1991-01-30 | 1994-09-20 | Interpore Orthopaedics, Inc. | Mesh sheet with microscopic projections and holes |
US5354338A (en) | 1991-02-22 | 1994-10-11 | Ledergerber Walter J | Texturized covering for implants |
US5271736A (en) | 1991-05-13 | 1993-12-21 | Applied Medical Research | Collagen disruptive morphology for implants |
US5135959A (en) | 1991-05-20 | 1992-08-04 | Sorrento Engineering Corporation | Method of impregnating reticulated foam with polymide foam and products thereof |
JP2571881B2 (en) | 1991-07-11 | 1997-01-16 | リグナイト株式会社 | Method for producing silicone porous body |
US5246454A (en) | 1991-07-22 | 1993-09-21 | Peterson Robert L | Encapsulated implant |
US5171269A (en) | 1991-08-29 | 1992-12-15 | Medical Engineering Corporation | Mammary prosthesis |
US5146933A (en) | 1991-09-20 | 1992-09-15 | Dow Corning Wright Corporation | Implantable prosthetic device and tethered inflation valve for volume |
US5376117A (en) | 1991-10-25 | 1994-12-27 | Corvita Corporation | Breast prostheses |
US5236454A (en) | 1991-11-04 | 1993-08-17 | Miller Archibald S | Stacked breast implant |
US5236457A (en) | 1992-02-27 | 1993-08-17 | Zimmer, Inc. | Method of making an implant having a metallic porous surface |
US5358521A (en) | 1992-04-01 | 1994-10-25 | Fred Shane | Multiple-layer prosthesis implant with tissue tactility |
US5534023A (en) | 1992-12-29 | 1996-07-09 | Henley; Julian L. | Fluid filled prosthesis excluding gas-filled beads |
US5964803A (en) | 1993-07-27 | 1999-10-12 | Pmt Corporation | Enhanced surface implant and method of manufacture |
US5545220A (en) | 1993-11-04 | 1996-08-13 | Lipomatrix Incorporated | Implantable prosthesis with open cell textured surface and method for forming same |
US5437824A (en) | 1993-12-23 | 1995-08-01 | Moghan Medical Corp. | Method of forming a molded silicone foam implant having open-celled interstices |
DE69521793T2 (en) | 1994-03-31 | 2002-08-08 | Ernest C. Manders | DIMENSIONALLY ADAPTABLE TISSUE EXTENSION DEVICE |
FR2721198B1 (en) | 1994-06-16 | 1996-10-31 | Caravel Jean Baudoin | Flexible implantable prosthesis, used in surgery for volume increase or soft tissue reconstruction, in particular breast prosthesis. |
DE69524845T2 (en) | 1994-11-01 | 2002-09-19 | Mentor Corp., Goleta | Method of texturing a soft implant using a porous shape |
US5549671A (en) | 1994-12-28 | 1996-08-27 | Mcghan Medical Corporation | Adjunctive filler material for fluid-filled prosthesis |
US5545217A (en) | 1995-04-20 | 1996-08-13 | C.M. Offray & Son, Inc. | Breast implant |
US6099565A (en) | 1995-06-07 | 2000-08-08 | Sakura, Jr.; Chester Y. | Prosthetic tissue implant and filler therefor |
FR2735354B1 (en) | 1995-06-13 | 1997-08-14 | Perouse Implant Lab | BREAST PROSTHESIS |
ATE257001T1 (en) | 1995-10-25 | 2004-01-15 | Sm Technologies Llc | METHOD FOR PRODUCING AN OBJECT FROM POROUS MATERIAL |
US6113634A (en) | 1996-04-23 | 2000-09-05 | F + E Gesellschaft fur Bekleidungsinnovation mbH & Co. KG | Breast prosthesis and method for making the same |
US5824081A (en) | 1996-09-13 | 1998-10-20 | Lipomatrix Incorporated | Hydraulic foam tissue implant |
US5935164A (en) | 1997-02-25 | 1999-08-10 | Pmt Corporaton | Laminated prosthesis and method of manufacture |
US6146418A (en) | 1997-02-28 | 2000-11-14 | Berman; Mark | Body implant and method of implanting |
BR9806174A (en) | 1997-03-26 | 1999-10-19 | Janssen Pharmaceutica Nv | Pellets having a core coated with an antifungal and a polymer |
US5961552A (en) | 1997-08-02 | 1999-10-05 | Pmt Corporation | Internally configured prosthesis |
US5965076A (en) | 1997-09-22 | 1999-10-12 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method for fabricating soft tissue implants with microscopic surface roughness |
WO1999020319A1 (en) | 1997-10-21 | 1999-04-29 | Augmentec Aktiengesellschaft Implantologie-Epithetik | Implant made of a reabsorbable ceramic material |
US6548569B1 (en) | 1999-03-25 | 2003-04-15 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
JP3400740B2 (en) | 1999-04-13 | 2003-04-28 | 東芝セラミックス株式会社 | Calcium phosphate porous sintered body and method for producing the same |
US6315796B1 (en) | 1999-05-13 | 2001-11-13 | Board Of Trustees Of The University Of Arkansas | Flexible seamless memory tissue expanding implant |
FR2794361B1 (en) | 1999-06-02 | 2001-10-19 | Arnaud Rochebiliere | BREAST PROSTHESIS |
US6432138B1 (en) | 2000-03-07 | 2002-08-13 | Promatrx, Inc. | Controlled porosity 3-D fabric breast prosthesis |
US20030105469A1 (en) | 2001-05-09 | 2003-06-05 | Regene Ex Ltd. | Bioresorbable inflatable devices, incision tool and methods for tissue expansion and tissue regeneration |
US6464726B1 (en) | 2000-07-13 | 2002-10-15 | Jenna Heljenek | Breast implant system and method of augmentation |
GB0030635D0 (en) | 2000-12-15 | 2001-01-31 | Aortech Internat Plc | Soft tissue implant |
FR2822383B1 (en) | 2001-03-23 | 2004-12-17 | Perouse Lab | PROSTHESIS FOR PLASTIC RECONSTRUCTION WITH IMPROVED HYDROPHILICITY PROPERTIES, AND METHOD FOR OBTAINING SAME |
US6605116B2 (en) | 2001-04-03 | 2003-08-12 | Mentor Corporation | Reinforced radius mammary prostheses and soft tissue expanders |
ES2190339B1 (en) | 2001-05-07 | 2004-11-01 | Ricardo Gonzalez De Vicente | PROTESIS FOR MOM. |
DE10135275A1 (en) | 2001-07-13 | 2003-01-30 | Jotec Gmbh | Implant and process for its manufacture |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
WO2003024698A1 (en) | 2001-08-24 | 2003-03-27 | Radiant Holdings, Llc | Method of producing silicone foam utilizing a mechanical foaming agent |
US20040176493A1 (en) | 2001-08-24 | 2004-09-09 | Ferguson Terrell W. | Silicone foam |
US6755861B2 (en) | 2001-10-16 | 2004-06-29 | Granit Medical Innovation, Inc. | Device for providing a portion of an organism with a desired shape |
US7613491B2 (en) * | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US7058439B2 (en) | 2002-05-03 | 2006-06-06 | Contourmed, Inc. | Methods of forming prostheses |
DE10224352A1 (en) | 2002-06-01 | 2003-12-11 | Mueller Schulte Detlef | Thermosensitive polymer carrier with changeable physical structure for biochemical analysis, diagnostics and therapy |
FR2840617B1 (en) | 2002-06-10 | 2004-09-10 | Rhodia Chimie Sa | PROCESS FOR PRODUCING POROUS SILICONE MATERIALS |
WO2004006806A1 (en) | 2002-07-10 | 2004-01-22 | Marlen Andreevich Sulamanidze | Endoprosthesis for reparative anaplastic surgery. |
US8048444B2 (en) | 2002-07-31 | 2011-11-01 | Mast Biosurgery Ag | Apparatus and method for preventing adhesions between an implant and surrounding tissues |
JP2006506385A (en) | 2002-10-22 | 2006-02-23 | ザ バイオメリックス コーポレーション | Methods and systems for intrathecal delivery of therapeutic agents |
JP2006516193A (en) | 2002-12-06 | 2006-06-29 | アイシス・ファーマシューティカルス・インコーポレーテッド | Rapid identification of pathogens in humans and animals |
US20050043585A1 (en) | 2003-01-03 | 2005-02-24 | Arindam Datta | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US20040143327A1 (en) | 2003-01-17 | 2004-07-22 | Ku David N. | Solid implant |
US7282241B2 (en) | 2003-04-22 | 2007-10-16 | International Business Machines Corporation | Patterned, high surface area substrate with hydrophilic/hydrophobic contrast, and method of use |
US7081135B2 (en) | 2003-06-09 | 2006-07-25 | Lane Fielding Smith | Mastopexy stabilization apparatus and method |
US7632291B2 (en) | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
US6802861B1 (en) | 2003-08-26 | 2004-10-12 | Rsh-Gs Trust | Structured breast implant |
AU2004268013B2 (en) | 2003-08-29 | 2011-05-12 | Mayo Foundation For Medical Education And Research | Hydrogel porogens for fabricating biodegradable scaffolds |
US7309232B2 (en) | 2003-10-10 | 2007-12-18 | Dentigenix Inc. | Methods for treating dental conditions using tissue scaffolds |
JP4452487B2 (en) | 2003-12-01 | 2010-04-21 | セイコーNpc株式会社 | Class D amplifier |
EP1786485A4 (en) | 2004-02-06 | 2012-05-30 | Georgia Tech Res Inst | Surface directed cellular attachment |
US7364592B2 (en) | 2004-02-12 | 2008-04-29 | Dexcom, Inc. | Biointerface membrane with macro-and micro-architecture |
US20070190108A1 (en) | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
US7674426B2 (en) | 2004-07-02 | 2010-03-09 | Praxis Powder Technology, Inc. | Porous metal articles having a predetermined pore character |
US7476249B2 (en) | 2004-08-06 | 2009-01-13 | Frank Robert E | Implantable prosthesis for positioning and supporting a breast implant |
US6932840B1 (en) | 2004-09-08 | 2005-08-23 | Absolute Breast Solutions | Implant device |
US7244270B2 (en) | 2004-09-16 | 2007-07-17 | Evera Medical | Systems and devices for soft tissue augmentation |
GB2421440A (en) | 2004-12-21 | 2006-06-28 | Ishay Wahl | Breast implant with securing means |
US20060224239A1 (en) | 2005-04-04 | 2006-10-05 | Tiahrt Leif K | Breast implant |
US7081136B1 (en) | 2005-04-18 | 2006-07-25 | Techno Investments Llc | Adjustable gel filled mammary prosthesis and method |
TWI382918B (en) | 2005-04-19 | 2013-01-21 | Sulzer Chemtech Ag | Uses of a method for the manufacture of foamed shaped polymer parts of liquid silicone rubber |
US8268344B2 (en) | 2005-04-27 | 2012-09-18 | The Regents Of The University Of Michigan | Particle-containing complex porous materials |
US20060282164A1 (en) | 2005-06-08 | 2006-12-14 | Joann Seastrom | Implant shell and filler apparatus |
US7368065B2 (en) | 2005-06-23 | 2008-05-06 | Depuy Products, Inc. | Implants with textured surface and methods for producing the same |
EP1940317B1 (en) | 2005-10-26 | 2012-06-13 | Allergan, Inc. | Variable cohesive gel form-stable breast implant |
US7547393B2 (en) | 2005-12-07 | 2009-06-16 | General Electric Company | Membrane structure and method of making |
US7625405B2 (en) | 2006-02-08 | 2009-12-01 | Neosthetic, Llc | Breast implant and method of manufacture |
FR2900089B1 (en) | 2006-04-21 | 2008-07-25 | Cereplas Soc | PROCESS FOR MANUFACTURING IMPLANTABLE MEDICAL DEVICES WITH TEXTURED SURFACE |
JP2008007458A (en) | 2006-06-29 | 2008-01-17 | Freunt Ind Co Ltd | Core particle for layering and method for producing the same |
WO2008008266A2 (en) | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
US7998152B2 (en) | 2006-12-21 | 2011-08-16 | Frank Robert E | Implantable prosthesis for periareolar mastopexy |
US8911765B2 (en) | 2007-03-29 | 2014-12-16 | Tyrx, Inc. | Biodegradable, polymer coverings for breast implants |
RU2340308C1 (en) | 2007-05-21 | 2008-12-10 | Константин Борисович Кубанцев | Mammary gland implant |
WO2009110917A1 (en) | 2007-06-07 | 2009-09-11 | Osteotherapeutics, L.L.C. | Bone cement compositions for use as growth factor carriers and methods of making same |
US7942930B2 (en) | 2007-06-15 | 2011-05-17 | Q-Med Ab | Biocompatible implant system and method |
US20110035004A1 (en) | 2007-11-14 | 2011-02-10 | Maxwell G | Interfaced medical implant |
US8425600B2 (en) | 2007-11-14 | 2013-04-23 | G. Patrick Maxwell | Interfaced medical implant assembly |
US20090171049A1 (en) | 2007-12-27 | 2009-07-02 | Linhardt Jeffrey G | Segmented reactive block copolymers |
US20090198331A1 (en) | 2008-02-01 | 2009-08-06 | Kesten Randy J | Implantable prosthesis with open cell flow regulation |
US20090198333A1 (en) | 2008-02-05 | 2009-08-06 | Hilton Becker | Method for texturing the surface of a synthetic implant |
US20090198332A1 (en) | 2008-02-05 | 2009-08-06 | Hilton Becker | Method for texturing the surface of a synthetic implant |
US8506627B2 (en) | 2008-08-13 | 2013-08-13 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
CA2761902C (en) | 2009-05-13 | 2019-03-05 | Allergan, Inc. | Implants and methods for manufacturing same |
US20110106249A1 (en) | 2009-09-02 | 2011-05-05 | Hilton Becker | Self supporting and forming breast implant and method for forming and supporting an implant in a human body |
US8197542B2 (en) | 2009-09-02 | 2012-06-12 | Hilton Becker | Self supporting implant in a human body and method for making the same without capsular contracture |
US8202317B2 (en) | 2009-09-02 | 2012-06-19 | Hilton Becker | Self supporting and forming breast implant and method for forming and supporting an implant in a human body |
US20110093069A1 (en) | 2009-10-16 | 2011-04-21 | Allergan, Inc. | Implants and methdos for manufacturing same |
KR101067475B1 (en) | 2009-11-19 | 2011-09-27 | 유원석 | Breast implant that has surface with silicone open cell foam layer, and its manufacturing method |
WO2011066441A1 (en) | 2009-11-25 | 2011-06-03 | Healionics Corporation | Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same |
CA2787824A1 (en) | 2010-01-28 | 2011-08-04 | Allergan, Inc. | Open celled foams, implants including them and processes for making same |
US20110276134A1 (en) | 2010-05-10 | 2011-11-10 | Allergan, Inc. | Silicone implant with imprinted texture |
US9044897B2 (en) | 2010-09-28 | 2015-06-02 | Allergan, Inc. | Porous materials, methods of making and uses |
US20110196488A1 (en) | 2010-02-03 | 2011-08-11 | Allergan, Inc. | Degradation resistant implantable materials and methods |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US20120041555A1 (en) | 2010-05-10 | 2012-02-16 | Allergan, Inc. | Silicone implant with imprinted texture |
US20120004722A1 (en) | 2010-02-03 | 2012-01-05 | Allergan, Inc. | Degradation resistant implantable materials and methods |
US8889751B2 (en) | 2010-09-28 | 2014-11-18 | Allergan, Inc. | Porous materials, methods of making and uses |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
CA2788265A1 (en) | 2010-02-05 | 2011-08-11 | Allergan, Inc. | Biocompatible structures and compositions |
EP2563851A1 (en) | 2010-04-27 | 2013-03-06 | Allergan, Inc. | Foam-like materials and methods for producing same |
CA2799196C (en) | 2010-05-10 | 2015-06-30 | Allergan, Inc. | Porous materials, methods of making and uses |
JP2013528067A (en) | 2010-05-11 | 2013-07-08 | アラーガン、インコーポレイテッド | Porogen materials, manufacturing methods, and uses |
PL2569021T3 (en) | 2010-05-11 | 2017-07-31 | Allergan, Inc. | Porogen compositions, methods of making and uses |
EP2582412A1 (en) | 2010-06-16 | 2013-04-24 | Allergan, Inc. | Open-cell surface foam materials |
US20120101574A1 (en) | 2010-08-20 | 2012-04-26 | Allergan, Inc. | Implantable materials |
US8765039B1 (en) | 2010-10-29 | 2014-07-01 | Walter J. Ledergerber | Implantable micro-textured scar inducing ePTFE structures |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
US8728159B2 (en) | 2010-12-01 | 2014-05-20 | Northwestern University | Prosthetic breast support |
US8546458B2 (en) | 2010-12-07 | 2013-10-01 | Allergan, Inc. | Process for texturing materials |
MX2012012801A (en) | 2012-11-01 | 2014-05-27 | Allan Arvizo Huerta | Process for generating mold for stylized breast. |
-
2008
- 2008-10-30 US US12/261,939 patent/US8313527B2/en active Active
- 2008-10-31 WO PCT/US2008/081940 patent/WO2009061672A1/en active Application Filing
- 2008-10-31 CA CA2704697A patent/CA2704697C/en active Active
- 2008-10-31 EP EP19163681.0A patent/EP3552581A1/en not_active Withdrawn
- 2008-10-31 ES ES08847491T patent/ES2728400T3/en active Active
- 2008-10-31 EP EP08847491.1A patent/EP2227175B1/en not_active Not-in-force
-
2011
- 2011-01-21 US US13/010,929 patent/US20110117267A1/en not_active Abandoned
-
2012
- 2012-10-24 US US13/659,803 patent/US9138310B2/en active Active
Patent Citations (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3189921A (en) * | 1962-04-11 | 1965-06-22 | William J Pangman | Compound prosthesis |
US3366975A (en) * | 1965-06-04 | 1968-02-06 | William J. Pangman | Compound prosthesis |
US3559214A (en) * | 1968-10-17 | 1971-02-02 | William J Pangman | Compound prosthesis |
US3665520A (en) * | 1970-10-07 | 1972-05-30 | Medical Eng Corp | Surgically implantable breast prosthesis |
US3934274A (en) * | 1974-10-29 | 1976-01-27 | Hartley Jr John H | Deflatable mammary augmentation prosthesis |
US4157085A (en) * | 1978-03-24 | 1979-06-05 | Dow Corning Corporation | Surgically implantable tissue expanding device and the method of its use |
US4264990A (en) * | 1979-01-24 | 1981-05-05 | Hamas Robert S | Mammary prosthesis |
US4433440A (en) * | 1979-02-26 | 1984-02-28 | Cohen I Kelman | Prosthesis formed by inner and outer inflatable containers |
US4650487A (en) * | 1980-10-27 | 1987-03-17 | Memorial Hospital For Cancer And Allied Diseases | Multi-lumen high profile mammary implant |
US4740208A (en) * | 1980-11-21 | 1988-04-26 | Cavon Joseph F | Cast gel implantable prosthesis |
US4428082A (en) * | 1980-12-08 | 1984-01-31 | Naficy Sadeque S | Breast prosthesis with filling valve |
US4482577A (en) * | 1980-12-16 | 1984-11-13 | Albert Goldstein | Coating process of elastomeric material |
US4329385A (en) * | 1980-12-19 | 1982-05-11 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Texturing polymer surfaces by transfer casting |
US4499211A (en) * | 1981-07-28 | 1985-02-12 | Hoechst Aktiengesellschaft | Open-cell/microporous molded article |
US4643733A (en) * | 1983-04-04 | 1987-02-17 | Hilton Becker | Permanent reconstruction implant and method of performing human tissue expansion |
US4573999A (en) * | 1983-10-14 | 1986-03-04 | Netto Daniel J | Human breast prosthesis |
US4803025A (en) * | 1984-04-23 | 1989-02-07 | Swiss Aluminium Ltd. | Ceramic foam |
US4648880A (en) * | 1984-08-30 | 1987-03-10 | Daniel Brauman | Implantable prosthetic devices |
US4636213A (en) * | 1985-01-24 | 1987-01-13 | Pakiam Anthony I | Implantable prosthesis |
US4651717A (en) * | 1985-04-04 | 1987-03-24 | Dow Corning Corporation | Multiple envelope tissue expander device |
US4592755A (en) * | 1985-06-11 | 1986-06-03 | Ethyl Corporation | Mammary implant |
US4936858A (en) * | 1986-07-22 | 1990-06-26 | Keeffe Paul O | Implantable fabric pouch for mammary prosthesis |
US5002572A (en) * | 1986-09-11 | 1991-03-26 | Picha George J | Biological implant with textured surface |
US5185297A (en) * | 1986-09-16 | 1993-02-09 | Lanxide Technology Company, Lp | Ceramic foams |
US4889744A (en) * | 1986-11-04 | 1989-12-26 | Medical Products Development Inc. | Method for making open-cell, silicone-elastomer medical implant |
US5007929B1 (en) * | 1986-11-04 | 1994-08-30 | Medical Products Dev | Open-cell silicone-elastomer medical implant |
US5007929A (en) * | 1986-11-04 | 1991-04-16 | Medical Products Development, Inc. | Open-cell, silicone-elastomer medical implant |
US4889744B1 (en) * | 1986-11-04 | 1993-03-09 | Method for making open-cell,silicone-elastomer medical implant | |
US4902294A (en) * | 1986-12-03 | 1990-02-20 | Olivier Gosserez | Implantable mammary prosthesis adapted to combat the formation of a retractile shell |
US4795464A (en) * | 1987-02-09 | 1989-01-03 | Tertulin Eberl | Artificial breast |
US5022942A (en) * | 1987-05-27 | 1991-06-11 | Mentor Corporation | Method of making textured surface prosthesis implants |
US4906423A (en) * | 1987-10-23 | 1990-03-06 | Dow Corning Wright | Methods for forming porous-surfaced polymeric bodies |
US4899764A (en) * | 1987-12-17 | 1990-02-13 | Dow Corning Wright | Tissue expander and method of making and using |
US4841992A (en) * | 1987-12-17 | 1989-06-27 | Dow Corning Wright Corporation | Tissue expander and method of making and using |
US5383929A (en) * | 1987-12-22 | 1995-01-24 | Ledergerber; Walter J. | Implantable prosthetic device |
US5282856A (en) * | 1987-12-22 | 1994-02-01 | Ledergerber Walter J | Implantable prosthetic device |
US6187043B1 (en) * | 1987-12-22 | 2001-02-13 | Walter J. Ledergerber | Implantable prosthetic device |
US4828560A (en) * | 1988-02-17 | 1989-05-09 | Mcgman Medical Corporation | Spring ring tissue expander |
US5104409A (en) * | 1989-01-10 | 1992-04-14 | Baker James L | Mammary implant |
US5026394A (en) * | 1989-01-10 | 1991-06-25 | Baker James L | Mammary implant |
US5092348A (en) * | 1989-01-17 | 1992-03-03 | Mcghan Medical Corporation | Textured tissue expander |
US5522896A (en) * | 1989-02-15 | 1996-06-04 | Xomed, Inc. | Biocompatible composite material |
US5116387A (en) * | 1989-06-09 | 1992-05-26 | American Medical Systems, Inc. | Preparation of injectable polymeric bodies |
US5007940A (en) * | 1989-06-09 | 1991-04-16 | American Medical Systems, Inc. | Injectable polymeric bodies |
US5092882A (en) * | 1990-05-04 | 1992-03-03 | Lynn Lawrence A | Multiple compartment breast prosthesis |
US5605693A (en) * | 1991-10-18 | 1997-02-25 | Seare, Jr.; William J. | Methods of making a porous device |
US5624674A (en) * | 1991-10-18 | 1997-04-29 | Seare, Jr.; William J. | Porous product mold form |
US5207709A (en) * | 1991-11-13 | 1993-05-04 | Picha George J | Implant with textured surface |
US5296069A (en) * | 1991-12-27 | 1994-03-22 | Silimed-Silicone E. Instrumental Medico Cirurgico E. Hosiptalar Ltda. | Process for manufacturing implants having coated surfaces |
US5496370A (en) * | 1992-03-13 | 1996-03-05 | Robert S. Hamas | Gel-like prosthetic device |
US5496367A (en) * | 1993-01-13 | 1996-03-05 | Fisher; Jack | Breast implant with baffles |
US5480430A (en) * | 1993-06-04 | 1996-01-02 | Mcghan Medical Corporation | Shape-retaining shell for a fluid filled prosthesis |
US5525275A (en) * | 1993-07-27 | 1996-06-11 | Pmt Corporation | Method of manufacture of enhanced surface implant |
US5607473A (en) * | 1994-06-20 | 1997-03-04 | Dr. Helbig GmbH & Co. Orthopadische Produkte KG | Breast prosthesis |
US5630843A (en) * | 1994-06-30 | 1997-05-20 | Rosenberg; Paul H. | Double chamber tissue expander |
US5507808A (en) * | 1994-10-26 | 1996-04-16 | Becker; Hilton | Filling tube and seal construction |
US6071309A (en) * | 1995-03-22 | 2000-06-06 | Knowlton; Edward W. | Segmental breast expander for use in breast reconstruction |
US5630844A (en) * | 1995-06-07 | 1997-05-20 | Novamed Medical Products Manufacturing, Inc. | Biocompatible hydrophobic laminate with thermoplastic elastomer layer |
US5895423A (en) * | 1996-02-23 | 1999-04-20 | Coloplast Corporation | Attachable two-chamber breast prosthesis |
US5855588A (en) * | 1996-10-03 | 1999-01-05 | General Surgical Innovations, Inc. | Combination dissector and expander |
US5871497A (en) * | 1996-10-03 | 1999-02-16 | General Surgical Innovations, Inc. | Combination dissector and expander |
US6074421A (en) * | 1997-04-05 | 2000-06-13 | Medisyn Technology, Ltd. | Seamless breast prosthesis |
US6881226B2 (en) * | 1997-10-10 | 2005-04-19 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US6214045B1 (en) * | 1997-10-10 | 2001-04-10 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US6387133B1 (en) * | 1998-07-16 | 2002-05-14 | Laboratoire Perouse Implant | Reconstruction implant |
US6206930B1 (en) * | 1998-08-10 | 2001-03-27 | Charlotte-Mecklenburg Hospital Authority | Absorbable tissue expander |
US6900055B1 (en) * | 1998-10-28 | 2005-05-31 | Cellon S.A. | Preparation of porous silicone rubber for growing cells or living tissue |
US6544287B1 (en) * | 1998-12-11 | 2003-04-08 | Gerald W. Johnson | Solid filled implants |
US6214926B1 (en) * | 1999-04-01 | 2001-04-10 | Rhodia Inc. | Silicone membranes formed without the use of 1-1-1 trichloroethane |
US6183514B1 (en) * | 1999-08-16 | 2001-02-06 | Hilton Becker | Self positioning breast prosthesis |
US20020038147A1 (en) * | 1999-10-22 | 2002-03-28 | Miller Archibald S. | Breast implant |
US6203570B1 (en) * | 1999-11-24 | 2001-03-20 | John L. Baeke | Breast implant with position lock |
US6692527B1 (en) * | 1999-12-01 | 2004-02-17 | Howard T. Bellin | Non-rotating breast implant |
US6520989B1 (en) * | 2000-01-18 | 2003-02-18 | Board Of Trustees Of The University Of Arkansas | Extreme volume flexible integrity prosthesis |
US6673285B2 (en) * | 2000-05-12 | 2004-01-06 | The Regents Of The University Of Michigan | Reverse fabrication of porous materials |
US6531523B1 (en) * | 2000-10-10 | 2003-03-11 | Renal Tech International, Llc | Method of making biocompatible polymeric adsorbing material for purification of physiological fluids of organism |
US20030093151A1 (en) * | 2000-12-22 | 2003-05-15 | Guangzhou Wanhe Material Co. Ltd. | Implantable mammary prosthesis with flexible sheet |
US20040010225A1 (en) * | 2001-07-18 | 2004-01-15 | Schuessler David J. | Rotationally molded medical articles |
US20030036803A1 (en) * | 2001-08-14 | 2003-02-20 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US20070116735A1 (en) * | 2002-07-31 | 2007-05-24 | Macropore Biosurgery, Inc. | Apparatus and method for preventing adhesions between an implant and surrounding tissues |
US20070093911A1 (en) * | 2003-04-28 | 2007-04-26 | Helmut Fricke | Soft tissue implant such as breast implant, calf muscle implant or the like |
US20050112169A1 (en) * | 2003-05-21 | 2005-05-26 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US7192450B2 (en) * | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US6875233B1 (en) * | 2003-06-10 | 2005-04-05 | Hinging breast implant | |
US20050055093A1 (en) * | 2003-09-03 | 2005-03-10 | Brennan William A. | System and method for breast augmentation |
US7169180B2 (en) * | 2003-09-03 | 2007-01-30 | Brennan William A | System and method for breast augmentation |
US20050070124A1 (en) * | 2003-09-30 | 2005-03-31 | International Business Machines Corporation | Direct photo-patterning of nanoporous organosilicates, and method of use |
US20080075752A1 (en) * | 2003-10-01 | 2008-03-27 | University Of Washington | Novel Porous Biomaterials |
US7645475B2 (en) * | 2004-03-03 | 2010-01-12 | Mentor Corporation | Devices having a textured surface |
US20060036320A1 (en) * | 2004-08-13 | 2006-02-16 | Keith Job | Spray method for forming shells for prostheses |
US7641688B2 (en) * | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
US7520896B2 (en) * | 2004-10-28 | 2009-04-21 | Fahd Benslimane | Breast implant, use of an associated pouch, and method for determination of a breast implant |
US7323208B2 (en) * | 2004-11-30 | 2008-01-29 | The Regents Of The University Of Michigan | Modified porous materials and method of forming the same |
US20090093878A1 (en) * | 2005-06-28 | 2009-04-09 | Ami Glicksman | Human implantable tissue expander |
US20070104693A1 (en) * | 2005-11-07 | 2007-05-10 | Quijano Rodolfo C | Breast augmentation system |
US20070104695A1 (en) * | 2005-11-07 | 2007-05-10 | Quijano Rodolfo C | Breast augmentation and reconstruction system |
US20090045166A1 (en) * | 2005-11-11 | 2009-02-19 | Yangyang Li | Method of enhancing biocompatibility of elastomeric materials by microtexturing using microdroplet patterning |
US20090087641A1 (en) * | 2005-11-14 | 2009-04-02 | Favis Basil D | Porous nanosheath networks, method of making and uses thereof |
US20080009830A1 (en) * | 2006-06-27 | 2008-01-10 | Fujimoto Kazuro L | Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions |
US20080071371A1 (en) * | 2006-09-20 | 2008-03-20 | Robert Elshout | Texturizing surfaces |
US20090082864A1 (en) * | 2007-09-19 | 2009-03-26 | Gaoyuan Gavin Chen | Naturally contoured, preformed, three dimensional mesh device for breast implant support |
US20090118829A1 (en) * | 2007-11-05 | 2009-05-07 | Allergan, Inc. | Soft prosthesis shell texturing method |
US20100042211A1 (en) * | 2008-08-13 | 2010-02-18 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
Non-Patent Citations (1)
Title |
---|
Adams, J.M., Particle Size and Shape Effects in Materials Science:Examples From Polymer and Paper Systems, 1993, Clay Minerals, Vol 28., pp 509-530 * |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9138310B2 (en) | 2007-11-05 | 2015-09-22 | Allergan, Inc. | Soft prosthesis shell texturing method |
US8506627B2 (en) | 2008-08-13 | 2013-08-13 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US9393106B2 (en) | 2008-08-13 | 2016-07-19 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US10765501B2 (en) | 2008-08-13 | 2020-09-08 | Allergan, Inc. | Dual plane breast implant |
US9918829B2 (en) | 2008-08-13 | 2018-03-20 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US10675144B2 (en) | 2008-08-13 | 2020-06-09 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US9848972B2 (en) | 2008-08-13 | 2017-12-26 | Allergan, Inc. | Dual plane breast implant |
US9138311B2 (en) | 2008-08-13 | 2015-09-22 | Allergan, Inc. | Soft filled prosthesis shell with discrete fixation surfaces |
US8951596B2 (en) | 2009-10-16 | 2015-02-10 | Allergan, Inc. | Implants and methods for manufacturing same |
US20120245685A1 (en) * | 2009-11-19 | 2012-09-27 | Won Seok Yu | Artificial breast implant provided on the surface threof with silicon open cell foam layer, and method for producing the same |
US9138308B2 (en) | 2010-02-03 | 2015-09-22 | Apollo Endosurgery, Inc. | Mucosal tissue adhesion via textured surface |
US10624997B2 (en) | 2010-02-05 | 2020-04-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9072821B2 (en) | 2010-02-05 | 2015-07-07 | Allergan, Inc. | Biocompatible structures and compositions |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US10391199B2 (en) | 2010-02-05 | 2019-08-27 | Allergan, Inc. | Porous materials, methods of making and uses |
US20110196489A1 (en) * | 2010-02-05 | 2011-08-11 | Allergan, Inc. | Biocompatible structures and compositions |
US8679570B2 (en) | 2010-04-27 | 2014-03-25 | Allergan, Inc. | Foam-like materials and methods for producing same |
US8685296B2 (en) | 2010-05-11 | 2014-04-01 | Allergan, Inc. | Porogen compositions, method of making and uses |
US11202853B2 (en) | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US8889751B2 (en) | 2010-09-28 | 2014-11-18 | Allergan, Inc. | Porous materials, methods of making and uses |
US8877822B2 (en) | 2010-09-28 | 2014-11-04 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9593224B2 (en) | 2010-09-28 | 2017-03-14 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9522502B2 (en) | 2010-09-28 | 2016-12-20 | Allergan, Inc. | Porous materials, methods of making and uses |
US9044897B2 (en) | 2010-09-28 | 2015-06-02 | Allergan, Inc. | Porous materials, methods of making and uses |
US9155613B2 (en) | 2010-11-16 | 2015-10-13 | Allergan, Inc. | Methods for creating foam-like texture |
US8679279B2 (en) | 2010-11-16 | 2014-03-25 | Allergan, Inc. | Methods for creating foam-like texture |
US8546458B2 (en) | 2010-12-07 | 2013-10-01 | Allergan, Inc. | Process for texturing materials |
US8801782B2 (en) | 2011-12-15 | 2014-08-12 | Allergan, Inc. | Surgical methods for breast reconstruction or augmentation |
US9688006B2 (en) | 2012-12-13 | 2017-06-27 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US10864661B2 (en) | 2012-12-13 | 2020-12-15 | Allergan, Inc. | Device and method for making a variable surface breast implant |
US10350055B2 (en) | 2014-05-16 | 2019-07-16 | Allergan, Inc. | Textured breast implant and methods of making same |
US9539086B2 (en) | 2014-05-16 | 2017-01-10 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
US9808338B2 (en) | 2014-05-16 | 2017-11-07 | Allergan, Inc. | Soft filled prosthesis shell with variable texture |
WO2017205835A1 (en) * | 2016-05-26 | 2017-11-30 | Allergan, Inc. | Production of rounded salt particles |
US11078085B2 (en) | 2016-05-26 | 2021-08-03 | Allergan, Inc. | Production of rounded salt particles |
Also Published As
Publication number | Publication date |
---|---|
US8313527B2 (en) | 2012-11-20 |
EP2227175B1 (en) | 2019-03-20 |
US20130053956A1 (en) | 2013-02-28 |
EP2227175A1 (en) | 2010-09-15 |
EP3552581A1 (en) | 2019-10-16 |
ES2728400T3 (en) | 2019-10-24 |
US20090118829A1 (en) | 2009-05-07 |
CA2704697C (en) | 2016-03-22 |
US9138310B2 (en) | 2015-09-22 |
CA2704697A1 (en) | 2009-05-14 |
WO2009061672A1 (en) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9138310B2 (en) | Soft prosthesis shell texturing method | |
US20240041586A1 (en) | Soft filled prosthesis shell with discrete fixation surfaces | |
AU2009282389B2 (en) | Soft filled prosthesis shell with discrete fixation surfaces | |
CA2761902C (en) | Implants and methods for manufacturing same | |
AU2015205876A1 (en) | Soft filled prosthesis shell with discrete fixation surfaces |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |